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ABSTRACT 
CYPl enzymes (CYPlAl，1A2, IBl) are ubiquitous members of cytochrome 
P450 superfamily. They play a key role in the metabolism of procarcinogens, such as 
4 
polycyclic aromatic hydrocarbons (PAHs), to their ultimate carcinogenic forms. 
Regulation of CYPl gene expression can be mediated through aryl hydrocarbon 
receptor (AhR). PAHs bind and activate AHR; this increases the transcription of 
CYPl gene and results in CYPl enzyme induction. The CYPl enzymes bio activate 
PAHs and generate genotoxic metabolites. These metabolites attack DNA and form 
PAH-DNA adducts which may lead to subsequent mutation. Recently, certain 
phytochemicals such as resveratrol are reported to inhibit CYPl activity. They 
reduce the risk of chemical carcinogenesis by either interfering the AHR-mediated 
transcriptional pathway or direct inhibiting CYPl enzymes. Their biochemical 
actions are believed to be an important part for chemoprevention of cancer. 
In this project, the effects of baicalein, (-)-epigallocatechin (EGCG)，four 
theaflavins (TFl, TF2A, TF2B and TF3) and 3 isoflavones (biochanin A, genistein 
and daidzein) on human CYPl A1/1B1 activities and DMBA-induced DNA damage 
in the human breast cancer cell line MCF-7 were examined. Preliminary screening 
showed that all of the above phytochemicals inhibited EROD activity in recombinant 
human CYPlAl and CYPIBI. Subsequent analysis indicated that only baicalein, 
biochanin A，EGCG and genistein did significantly inhibit DMBA-induced EROD 
activities in MCF-7 cells. Baicalein, EGCG, genistein and biochanin A treatments 
also reduced DMBA-induced CYPlAl and CYPIBI gene expressions as measured 
by semi-quantitative RT-PCR, while theaflavins and daidzein had no effect at this 
level. Transient transfection studies showed that baicalein, biochanin A, EGCG and 
genistein suppressed the XRE-dependent gene transcription. Furthermore, 
iii 
DMBA-DNA adduct formation was reduced after the addition of the above 
phytochemicals. Interestingly, theaflavins did inhibit DMBA-induced DNA damage 
without affecting CYPl enzymes activities and expression. This indicated that 
theaflavins might exert their anti-tumorigenic ability through other mechanisms. In 
conclusion, baicalein, biochanin A, EGCG and genistein likely inhibited 
DMBA-induced carcinogenesis via the intervention of AhR-mediated transcriptional 
pathway and CYPIAI/CYPIBI activities. Although theaflavins also diminished the 
damage of DMBA in other studies, they did not alter DMBA-induced CYPlAl and 

















素的活性，但是只有baicalein�genistein�biochanin A and EGCG能有效修飾 
MCF-7因DMBA誘導的CYPl酵素的活性。反轉錄聚合腾鏈式反應(RT-PCR) 
實驗證明 baicalein�genistein�biochanin A 與 EGCG 芾丨J止 DMBA 誘導的 CYPl 
信使核醣核酸(mRNA)的表達。之後我們再以XRE-Luc微量質體做過渡性基因 
轉(transient transfection)的實驗，結果亦顯示 baicalein�genistein�biochanin A 禾口 
EGCG能抑制CYPl轉錄依賴性螢光酵素的表現。本篇的結果，告訴我們 






AHR Aryl hydrocarbon receptor 
APS Ammonium persulfate 
ARNT Aryl hydrocarbon receptor nuclear translocator 
B[a]P Benzo[a]pyrene 
CYP or P450 Cytochrome P450 
DMBA 7, 12-dimethylbenz[a]anthracene 
DMSO Dimethyl sulfoxide 
EGCG (-)-epigallocatechin gallate 
EROD Ethoxyresorufin-O-deethylase 
GST Glutathione-S -transferase 
Hsp90 Heat shock protein 90 
MROD methoxyresorufin-O-demethylase 
MTT 3"(4,5 dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
OME Omeprazole 
PAH Polycyclic aromatic hydrocarbons 
PAS Per-Amt-Sim 
PBS phosphate-buffered saline 
PGR Polymerase chain reaction 
ROS Reactive oxygen species 
RT-PCR Reversed transcription - polymerase chain reaction 
SDS Sodium codicil sulphate 





XRE Xenobiotics responsive element 
p-NADPH p-Nicotinamide adenine dinucleotide phosphate, reduced form 
vi 





TABLE OF CONTENTS. VII 
LIST OF FIGURES AND TABLES XI 
CHAPTER 1 GENERAL INTRODUCTION 1 
Xenohiotic-metaholizing enzymes 1 




Transactivation ofCYPl enzymes hyAryl hydrocarbon receptor (AhR) 8 
Implication ofPAHs and CYPl family in breast cancer 10 
Potential role of phytochemicals on cancer prevention 11 
Significance of this project 13 
CHAPTER 2 MATERIALS AND METHODS 14 
Chemicals 14 
Maintenance of cells 14 
Preparation of cell stock 14 
Cell recovery from liquid nitrogen stock 15 
Measurement of cell viability 15 
Preparation of cell lysates (NP-40 cell lysis buffer) 15 
XRE-luciferase gene reporter assay 16 
MANIPULATION OF D N A AND R N A 17 
vii 
Separation and purification of DNA from agarose gel 17 
Separation ofDNA from acrylamide gel 17 
Restriction digestion  
Ligation ofDNA fragments 18 
Transformation ofDHSa 19 
Small scale plasmid purification from DH5a (mini prep) 19 
Large scale plasmid isolation from DH5a (maxi-prep) 20 
Construction of XRE activated luciferase reporter gene 21 
Measurement of DMBA-DNA adduct formation 21 
Semi-quantitative RT-PCR Assay 22 
ENZYME AcxivrnES 23 
Isolation of microsomes 23 
EROD activities in intact cells 23 
EROD inhibition assay 24 
STATISTrCAL ANALYSIS 24 
CHAPTER 3 BAICALEIN INHIBITS DMBA-DNA ADDUCT 
FORMATION BY MODULATING CYPlAl AND IBl ACTIVITIES 26 
INTRODUCTION 26 
RESULTS 28 
EROD activities in MCF-7 cells and inhibition assay 28 
Baicalein suppressed DMBA-induced XRE-driven luciferase activities 31 
Baicalein inhibited DMBA-induced CYPlAl and CYPIBI mRNA expression. 31 
The cytotoxic effect of DMBA was reduced by baicalein 35 
Inhibition of DMBA-DNA adduct formation after baicalein treatment 35 
DISCUSSION 39 
CHAPTER 4 INHIBITION OF DMBA-DNA ADDUCT FORMATION BY 




Persistence of DMBA-induced DMA adducts 45 
Inhibition of theaflavins and EGCG on human recombinant CYPlAl and 
CYPIBI enzyme activities 48 
EGCG suppressed DMBA-induced EROD activity while thealfavin had no 
significant effect on this 48 
Kinetic analysis of EGCG on CYPlAl and CYPIBI activities 53 
Modulation of DMBA-induced XRE-driven luciferase activities by theaflavins 
and EGCG  
The influence of theaflavins and EGCG on CYPlAl and CYPIBI abundance. 56 
DISCUSSION 65 
CHAPTER 5 ISOFLAVONES PREVENT DMBA-INDUCED 




Isoflavones inhibited DMBA-induced EROD activity in MCF-7 cells 70 
Inhibition of MCF-7 microsomal EROD activities by isoflavones 70 
Kinetic analysis of the inhibition of human recombinant CYPl enzymes by 
isoflavones 74 
XRE-driven Luciferase activities 83 
Both hiochanin A and genistein suppressed DMBA-induced CYPl mRNA 
expression 83 
Cytotoxicity of DMBA and isoflavones co-treatment 88 
Isoflavones reduced the binding of activated DMBA to DNA 89 
DISCUSSION 93 
CHAPTER 6 IN VITRO EFFECTS OF BAICALEIN AND THEAFLAVINS 
ON RAT HEPATIC P450 ACTIVITIES 96 
INTRODUCTION 96 
RESULTS 98 
Inhibition of EROD and MROD activities in rat liver microsomes by baicalein 
98 
ix 
Effects of theaflavins on EROD and MROD activities in rat liver microsomes 
102 
Kinetic studies for EROD and MROD activities of theaflavins 104 
DISCUSSION 114 
CHAPTER 7 CONCLUSION 116 
APPENDIX 1 PRIMER LISTS 118 
APPENDIX 2 REAGENTS 119 
BIBLIOGRAPHY 121 
xi 
LIST OF FIGURES AND TABLES 
Figure 1.1 Phase I and phase n reactions involved in biotransformation 3 
Figure 1.2 Reactive metabolites of B[a]P and DMBA and the principle 
adducts that they form with DNA (Adopted from Dipple et al., 
1994) 7 
Figure 1.3 Transactivation of CYPl gene by AhR 9 
Table 1.1 Effects of food phytochemicals on xenobiotic metabolism 12 
Figure 3.1 Picture of Scutellariae radix and the structure of baicalein 27 
Figure 3.2 Baicalein inhibited DMBA-induced EROD activity in MCF-7 
ceUs 29 
Figure 3.3 Baicalein competitively inhibited microsomal EROD activity……30 
Figure 3.4 Effect of baicalein on XRE-driven luciferase activities 32 
Figure 3.5 Effect of baicalein on DMBA-induced XRE-driven luciferase 
activities 33 
Figure 3.6 The influences of baicalein on mRNA abundance of CYPl Al and 
CYPIBI 34 
Figure 3.7 Cytotoxicity of DMBA and baicalein co-treatment 36 
Figure 3.8 The cytotoxic effect of baicalein alone on MCF-7 cells 37 
Figure 3.9 DMBA-DNA adduct formation in MCF-7 cells after baicalein 
treatment 38 
Figure 4.1 Chemical structures of theaflavins and EGCG 44 
Figure 4.2 Pattern of DMBA-DNA adduct formation in MCF-7 cells treated 
with theaflavins 46 
Figure 4.3 EGCG suppressed DMBA-DNA adduct formation 47 
xi 
Figure 4.4 Effects of theaflavins and EGCG on recombinant CYPlAl and 
CYPIBI EROD activities 49 
Figure 4.5 Effects of theaflavins on DMBA-induced EROD activities 50 
Figure 4.6 Effect of theaflavins on DMBA-induced EROD activities"………51 
Figure 4.7 EROD activities in MCF-7 cells treated with EGCG alone 52 
Figure 4.8A Lineweaver-Burk plot of EGCG on CYPlAl enzymes 
inhibition 54 
Figure 4.8B Lineweaver-Burk plot of EGCG on CYPlAl enzymes 
inhibition 55 
Figure 4.9 Effects of theaflavins on DMBA-induced XRE-mediated CYPl 
transcription 57 
Figure 4.10 Effect of EGCG on DMBA-induced XRE-mediated luciferase 
activity 58 
Figure 4.11 Effects of EGCG alone on XRE-driven luciferase activities 59 
Figure 4.12 CYPIAI/CYPIB1 mRNA expressions in MCF-7 cells treated with 
TFl and DMBA 60 
Figure 4.13 CYPlAl/CYPIB 1 mRNA expressions in MCF-7 cells treated with 
TF2A and DMBA 61 
Figure 4.14 CYPIAI/CYPIB1 mRNA expressions in MCF-7 cells treated with 
TF2B and DMBA 62 
Figure 4.15 CYPl Al/CYPIB 1 mRNA expressions in MCF-7 cells treated with 
TF3 and DMBA 63 
Figure 4.16 DMBA-induced CYPlAl and CYPIBI mRNA expression were 
inhibited by EGCG cotreatment 64 
Table 5.1 Chemical structures of isoflavones 69 
xii 
Figure 5.2 Diverse effects of isoflavones on DMBA-induced EROD activities. 
71 
Figure 5.3 Inhibitory effects of isoflavones alone on EROD activities 72 
Figure 5.4 Effects of isoflavones on microsomal EROD activities 73 
Figure 5.5 Inhibition of isoflavones on human recombinant C Y P l A l and 
CYPIBI activities 75 
Figure 5.6A Lineweaver-Burk plot ofbiochanin A on C Y P l A l enzymes 
inhibition 76 
Figure 5.6B Lineweaver-Burk plot ofbiochanin A on CYP IB 1 enzymes 
inhibition 77 
Figure 5.7A Lineweaver-Burk plot of genistein on CYPlAl enzymes 
inhibition 78 
Figure 5.7B Lineweaver-Burk plot of genistein on CYPIBI enzymes 
inhibition 79 
Figure 5.8A Lineweaver-Burk plot of daidzein on CYPlAl enzymes 
inhibition 80 
Figure 5.8B Lineweaver-Burk plot of daidzein on CYP IB 1 enzymes 
inhibition 81 
Figure 5.9 Competitive Ki value for isoflavones on CYPl inhibition 82 
Figure 5.10 Differential effects of isoflavones on DMBA-induced XRE-driven 
luciferase activities 84 
Figure 5.11 Effects of isoflavones alone on XRE-driven luciferase activities..85 
Figure 5.12 Effect ofBiochanin A on DMBA-induced CYPlAl and CYPIBI 
mRNA expression 86 
Figure 5.13 Effect of genistein on DMBA-induced CYPl mRNA expression.87 
Figure 5.14 Effect of daidzein on DMBA-induced CYPl mRNA expression..88 
xiii 
Figure 5.15 The cytotoxic effects of DMBA and isoflavones on MCF-7 cells.90 
Figure 5.16 The cytotoxic effects of isoflavones on MCF-7 cells 91 
Figure 5.17 The influences of isoflavones on [^H]DMBA -DNA adduct 
formation 92 
Figure 6.1 Direct effects of baicalein on microsomal EROD and MROD 
activity 99 
Figure 6.2 Lineweaver-Burk plot of baicalein on the EROD inhibition 100 
Figure 6.3 Lineweaver-Burk plot of baicalein on the MROD inhibition ……101 
Figure 6.4 Direct effects of theaflavins on microsomal EROD and MROD 
activities 103 
Figure 6.5 Lineweaver-Burk plot of TFl on the EROD inhibition 105 
Figure 6.6 Lineweaver-Burk plot of TFl on the MROD inhibition 106 
Figure 6.7 Lineweaver-Burk plot of TF2A on the EROD inhibition 107 
Figure 6.8 Lineweaver-Burk plot of TF2A on the MROD inhibition 108 
Figure 6.9 Lineweaver-Burk plot of TF2B on the EROD inhibition 109 
Figure 6.10 Lineweaver-Burk plot of TF2B on the MROD inhibition 110 
Figure 6.11 Lineweaver-Burk plot of TF3 on the EROD inhibition I l l 
Figure 6.12 Lineweaver-Burk plot of TF3 on the MROD inhibition 112 
Figure 6.13 Competitive Ki value for baicalein and theaflavins on EROD and 
MROD inhibition 113 
xiv 
CHAPTER 1 GENERAL INTRODUCTION 
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous toxicants that are 
commonly found in our environment, such as diesel exhaust, char-broiled meat, 
tobacco smoke, over-heated cooking oil, etc (lARC, 1983; EPC, 1990). Studies have 
showed that PAHs elicit a board spectrum of adverse biological responses including 
tumor promotion, immunosuppression, cardiovascular diseases and hormonal 
dysregulation (Birbnaum, 1994; Couture et al, 1994; Nebert et al，1993). Apart from 
this, PAHs are reported to be genotoxic and capable of forming carcinogen-DNA 
adducts in human or animal tissues (Dipple et al, 1984; Kriek et al, 1998). Upon 
exposure, PAHs are metabolized to reactive PAHs intermediates mediated by 
cytochrome P450s, drug-metabolizing enzymes that play a major role in the 
activation of hydrophobic xenobiotics. These activated epoxide diol metabolites bind 
to mutational hotspots of critical genes including p53 tumor suppressor gene, may 
initiate tumorigenesis (Smith et al, 2000). Moreover，a higher amount of 
DNA-adduct is observed in various tumor tissues including breast, lung and stomach 
(Li et al, 1996; Lee et al, 1998; Li et al, 2001). 
Xenobiotic-metabolizing enzymes 
The metabolism of xenobiotics is catalyzed by a number of enzymes which are 
involved in phase I and phase n reactions (Figure 1.1). Phase I reactions including 
oxidation, hydroxylation and reduction, result in reactive metabolites that can be 
further metabolized by phase II enzymes and excreted. Cytochrome P450s are the 
most extensively studied phase I enzyme systems that are responsible for the 
oxidation of a large number of xenobiotics such as PAHs (Gonzalez et al, 1994). The 
1 
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products of phase I reactions are usually substrates for the phase H enzymes, but 
some xenobiotics can be directly conjugated to awter-soluble moieties bypassing 
phase I enzymes. Phase H detoxification enzymes such as glutathione-S-transferase 
are involved primarily in conjugation reactions. The conjugated chemicals can then 
be excreted. Although the phase I and phase n enzymes are believed to be evolved 
for the detoxification of xenobiotics, they are also involved in the generation of 
reactive intermediates. These active electrophiles may attack cellular 
macromolecules, leading to toxicity or carcinogenicity. Cytochrome P450s are 
reported to play an essential role in the activation of a variety of toxicants and 
carcinogens. 
2 
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Phase I Phase II 
^ , , rMCAi Glutathione ^-transferase Cytochrome P4501 … � ^ Sulfotransferase etc 
Xenobiotics — — > Reactive 一 — — Excretable 
Oxidation, e l e c — e s G 一 她 - m 編 ^^ ^ 
hydrolysis etc 
\ Urine, stools 
Malignant Attack of macromolecules 
transformation — Mutation — uke DNA, RNA 
Figure 1.1 Phase I and phase II reactions involved in biotransformation. 
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Cytochrome P450 1 family 
Cytochrome P450 (CYP) monooxygenases are a superfamily of microsomal 
hemeproteins. They metabolize a number of endogenous compounds such as 
estradiol and fatty acids and an infinite number of exogenous substances 
(xenobiotics). CYPl subfamily containing CYPlAl, CYP1A2 and CYPIBI is the 
most ubiquitous of all cytochrome P450 families, and is inducible by PAHs via the 
aryl hydrocarbon receptor (AhR) transactivation pathway. The family is featured by 
its specificity of substrates in a planer molecular configuration, such as PAHs, TCDD. 
Thus, PAHs are not only the substrates but they also are inducers of CYPl enzymes. 
A major characteristic, which distinguishes CYPl from other cytochrome P450 
families, is their propensity to metabolize compounds at site and generate reactive 
electrophiles (Guengerich et al.，1998). In the presence of epoxide hydroxylase, 
CYPl enzymes catalyze the conversion of benzo[a]pyrene into mutagenic diol 
epoxides (Shimada et al., 1999; Kim et al.，1998). Biotransformation of DMBA is 
found to be dependent on CYPlAl/ lBl (Conney et al.，1994; Larsen et al.，1998). 
The metabolites from the above reactions intercalate with DNA and may lead to 
cancer (Figure 1.2). This explains the significance of CYPl enzymes in the 
biotransformation of chemical carcinogens into genotoxic moieties. Furthermore 
CYPlAl induction has long been considered as a biomarker of identifying 
individuals with high cancer risk. (Karki et al., 1987; Guengerich, 1991; Kawajiri et 
al., 1993) A more detail information on the characteristic of individual CYPl 
enzymes is given below. 
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CYPlAl 
CYPlAl is the most studied enzyme in the CYPl family. It is mainly 
extrahepatic and is responsible for the metabolism of PAHs. Constitutive expression 
of CYPlAl in human and rat liver is hardly detectable but it is highly inducible in 
liver and other tissues by PAHs. It is one of the AhR battery genes and is also 
possible to be activated by other ligand independent pathways induced by 
omeprazole (OME) (Backlund et al.，1997). CYPlAl polymorphism affects its 
enzyme level toward PAHs, i.e., more readily inducible variant can produce greater 
carcinogenic activation (Schwarz et al., 2001). Woman with CYPlAl polymorphism 
who also smoked cigarettes has a higher risk of lung cancer. 
CYPlAl 
Human CYP1A2 is the most abundantly expressed CYPl enzyme in the liver 
(Landi, 1999). Substrates for metabolic activation by CYP1A2 include aminoflurenes, 
nitrosamines and a number of PAHs. Unlike CYPlAl, the molecular mechanism 
underlying the induction of CYP1A2 is obscure. It is because the constitutive or 
inducible expression of CYP1A2 is exceptionally low (Roberts et al., 1994) or even 
absence in human or other mammalian cell lines even though it is one of the most 
abundant P450s in human liver. 
CYPIBI 
CYPIBI is expressed in a tissue-specific manner and can be induced by AhR 
ligands. Not only does it bio activate PAHs and aryl amines, but it is also a 
5 
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catalytically efficient estradiol 4 hydroxylase that is likely to participate in endocrine 
regulation and the toxicity of estrogen. CYPIBI 冲pears to be more active than 
CYPlAl in the conversion of a number of PAHs to their genotoxic intermediates 
(Shimada et al., 1996). Low levels of CYPIBI mRNA have been observed in normal 
human tissue (Sutter et al., 1994; WiUey et al., 1997; Vadlamuri et al , 1998)，while 
CYPIBI protein has only been detected in cancer cells, e.g. mammary fibroblast 
(McKay et al., 1995; Murray et al.，1997). Elevated CYPIBI expression and putative 
CYPIBI catalyzed E2 4，-hydroxylation have been suggested to be probable 
biomarkers of carcinogenesis in several tissues including breast and uterus 
myometrium (Spink et al.，1998). 
6 
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Figure 1.2 Reactive metabolites of B[a]P and DMBA and the principle 
adducts that they form with DNA (Adopted from Dipple et al., 1994). 
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Ti-ansactivation of CYPl enzymes by Aryl hydrocarbon receptor (AhR) 
What are the mechanisms governing CYPl induction and how are they 
regulated? Studies have implicated that Ah receptor (AhR) plays a pivotal role in 
regulating the transcription of CYPl enzymes. Ah receptor is a ligand-activated basic 
helix-loop-helix (bHLH) transcriptional factor, which belongs to the PAS 
(Per-Amt-Sim) homology domain family. Unliganded AhR in cytoplasm is 
associated with two 90kDa heat shock proteins and immunophilin chaperon, 
AhR-interacting protein (AIP). Binding to ligands like PAHs triggers the 
conformational change of AhR, which results in the dissociation of AhR with the 
complex. The activated AhR translocates into the nucleus and subsequently 
dimerizes with aryl hydrocarbon receptor nucleus translocator (ARNT). The 
ligand-bound heterodimer binds xenobiotic responsive elements (XRE) and can 
initiate gene transcriptions with the recruitment of coactivators and other general 
transcription factors (Figure 1.3). XRE with the core sequence ‘TNGCGTG” is 
present in the promoter regions of several genes involved in the metabolism of 
xenobiotics, including cytochrome P450 1 family (Chang et al., 1998; Tian et al.， 
1999; Kronenberg et al.，2000). 
To determine whether AhR plays a role in modulating carcinogenesis through 
the induction of xenobiotic-metabolizing enzymes, Shimizu et al. (2000) expose 
AhR-deficient mice to benzo[a]pyrene (B[a]P). They find that the carcinogenicity of 
this agent is lost in AhR-deficient mice, while cytochrome p450 lAl has been 
implicated to be responsible for the toxicity of B[a]R In another CYPIBI knockout 
mouse model，fewer DMBA-induced lymphoma incidences have been reported in the 
null mice (Buters et al., 1999). From these data, the positive roles of AHR, CYPlAl, 
and CYPIBI in PAH-induced carcinogenesis are substantiated. 
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Figure 1.3 Transactivation of CYPl gene by AhR 
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Implication of PAHs and CYPl family in breast cancer 
Some mammary carcinogens can be transformed by phase I enzymes and attack 
DNA, and constant exposure over time may result in an accumulation of gene 
mutation in certain critical genes like p53. Carcinoma development only occurs when 
» 
those mutations impair normal cell cycle regulation. To date, the significance of 
PAHs and CYPl family expression in breast cancer still remain unclear, as no 
conclusive effects can be drawn. While PAH-DNA adduct may also be formed and 
accumulate in breast tumor, breast cancer risk cannot be predicted from the level of 
PAH-DNA adduct in normal breast tissue (Williams et al.，2000; Rundle et al.，2000). 
Nevertheless, as researches have indicated that mammary gland is susceptible to 
tumor initiation by DNA-damaging agents like PAHs, it would therefore be 
surprising if exposing xenobiotic genotoxins do not have a consequence for tumor 
initiation. Studies have shown that a single injection of DMBA, a synthetic PAH, 
induce mammary tumor in rat. Acute exposure to benzo[^z]pyrene inhibits the 
expression of BRCA-1, a major tumor suppressor gene, in breast cancer cells (Jeffy 
et al.，1999). Furthermore, it is conceivable that people with certain alleles of 
polymorphic genes encoding higher expressions of metabolizing enzymes would lead 
to increased rates of breast cancer. Polymorphisms of CYPlAl and CYPIBI have 
been related to a high risk of breast cancer (Hanna et al., 2000). 
Benzo[a]anthracene-mediated induction of CYPlAl expression is paralleled by 
increases in the formation of IQ-DNA adducts (Williams, 1998). Studies indicate that 
CYPIBI mediated E2 4 hydroxylation is higher in human breast tumor compared 
with normal breast cells. (Trombino et al., 2000) Moreover, the dysregulation of 
AhR, CYPlAl and CYPIBI have been suggested to be the molecular biomarkers for 
PAH-induced mammary cell transformation (Dialyna et al., 2001). 
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Potential role of phytochemicals on cancer prevention 
Experimental and epidemiological data have revealed that certain 
phytochemicals are effective in preventing neoplastic development and 
carcinogen-induced DNA damages. They exert a multiplicity of biochemical actions 
that is believed to be responsible for their chemopreventive actions on cancer. 
Antioxidants like polyphenols from green tea function as nucleophile-interacting 
electrophiles prevent carcinogen bioactivation to form PAH-DNA adduct. Other 
phytochemicals such as curcumin suppress tumor progression by inhibiting cell 
proliferation enzymes and induce 叩optosis of tumor cells. One of the most 
significant mechanisms by which these compounds may perform their putative 
anticancer effects is through the modulation of phase I activating enzymes and phase 
n detoxifying enzymes. Table 1.1 shows the effects of certain phytochemicals on 
xenobiotic metabolism and the related enzymes. Phytochemicals may affect gene 
transcription and translation of specific xenobiotic metabolizing enzymes as well as 
the degradation of their mRNA and protein. 
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CHAI'lliR 1 
Compounds Effects Xenobiotic metabolism and enzymes 
Quercetin Hi Elhoxyrcsorufin 0-dccthylasc activities, 
aryl hydrocarbon hydroxylase 
Naringenin ii Ethoxyresorufin 0-dccthylase activities， 
metabolism of bcnzo[a]pyrcnc 
Indole-3-carbinol T P450s lAl, 2B1, UDP-glucuronyl transferase, 
pentoxyresorufin 0-dealkylase activities, 
Umonene T P450, P450s 2B，2C 
TT DMBA metabolism 
Flavones T P450, glutathione ^^-transferase 
ii Ethoxyresorufin 0-deethylase activities 
Table 1.1 Effects of food phytochemicals on xenobiotic metabolism. 
(Modified from Smith et al, 1994). 
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Significance of this project 
To find out the potential role of phytochemicals in drug-metabolizing enzyme 
modulation, extensive studies have been carried out to delineate the effects of 
phytochemicals on CYPl activating enzymes. Researches indicate that inhibition of 
CYPl enzymes is beneficial in the prevention of PAH-DNA adduct formation in vivo 
and in vitro, possibly by reducing the formation of activated intermediates. Galangin 
from India root suppresses DMBA-DNA adduct formation in a breast cancer cell line 
by acting as an inhibitor of CYPlAl activity and an agonist of AhR (Ciolino et al, 
1999); whereas furanocoumarins prevents DMBA diol-epoxide formation catalyzed 
by CYPl enzymes in female SENCAR mice (Kleiner et al., 2002). 
In light of this, we would Mke to address the effects of certain phytochemicals 
including baicalein, isoflavones and theaflavins on CYPl enzyme regulation and the 
DNA-adduct formation in the breast tumor cell line MCF-7 in response to DMBA. 
Studies have demonstrated that MCF-7 cells expressing CYPlAl and CYPIBI are 
similar to normal human mammary epithelial cells with regard to AhR expression 
and CYPlAl activity (Larson et al.，1998). A synthetic PAH, DMBA, is chosen 
because k is a mammary carcinogen that has been used extensively as a prototypical 
agent in cancer research. Not only does it act as an inducer for CYPl transcription 
but is also a substrate of CYPl enzymes. The activated DMBA intermediates can 
covalently bind to DNA that may trigger DNA damage. Since certain 
phytochemicals have been shown.to be AhR antagonists that render the induction of 
CYPl enzymes, the present study will investigate the effects of phytochemicals on 
DMBA-induced XRE transactivation. 
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CHAPTER 2 MATERIALS AND METHODS 
Chemicals 
Baicalein, EGCG, genistein, biochanin A and daidzein were obtained from 
Sigma-Aldiich, Milwaukee, WA, U.S.A. Ethoxyresomfm, and DMBA were 
purchased from Sigma Chemicals (St Louis, MO, USA). The carrier solvent DMSO 
was also obtained from Sigma Chemicals. All other chemicals, if not stated，were 
acquired from Sigma Chemicals.. 
Maintenance of cells 
MCF-7 cells (gift from Dr. V.C. Jordan) were grown in RPMI - 1640 phenol red 
free media (Sigma Chemicals) supplemented with 50 units/ml Penicillin 
-Streptomycin (GibcoBRL, USA) and 10% v/v fetal bovine serum (Invitrogen Life 
Technology, Rockville, MD) in a humidified incubator at 37�C，in 5% CO2. When 
cells reached about 80% confluence, the medium was removed and the cells were 
trypsinized with 3 ml trypsin-EDTA for 3 min. The cell suspension was transferred to 
a 15-ml centriftige tube containing 7 ml PBS and centrifuged at 1,000 rpm at room 
temperature for 5 min. The cell pellet was resuspended with fresh medium and 
transferred to new flasks and incubated as described above. 
Preparation of cell stock 
Semi-confluent cells in 75 cm^ flasks were washed with PBS and trypsinized as 
described above. After centrifugation, the cell pellet was suspended in 450 |il of 
RPMI supplemented with 10% v/v FBS and transferred into a 2-ml freezing tube 
containing 450 of FBS and 100 \i\ of DMSO. The tube was put in an 
isopropanol-filled freezing container (Nalgene, USA) and the container was put into 
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a -80°C freezer so that the cell stock was frozen at a constant rate of about 1 � C /min. 
cell stocks were stored at -80°C or liquid nitrogen. 
Cell recovery from liquid nitrogen stock 
The cell stock was taken out from the liquid nitrogen tank and thawed 
immediately in a 37°C water bath. To remove the DMSO, the cell stock was diluted 
into 10 ml of RPMI with 10% v/v FBS. The cell suspension was centrifuged as 
described above and the supernatant was discarded. The cell pellet was then 
suspended in 10 ml of RPMI with 10% v/v FBS，plated on a 75 cm^ culture flask and 
incubated as above. Medium was changed one day after recovery of the cells. 
Measurement of cell viability 
Cell viability was assessed by 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) straining as described by Mosmann (1983). Briefly, 
MCF-7 cells were plated in 96-well plates at lO* cells per well, and 1 (iM DMBA 
and various concentrations of phytochemicals were administered for 24 h. At the end 
of the treatment, 50 |il of 1 mg/ml MTT was added and the cells were incubated at 
37�C for 4 h. Then 100 |il of DMSO was added and the plate was allowed to stand at 
room temperature for 30 min. Cell viability was determined by the absorbance at 
600nra. 
Preparation of cell lysates (NP-40 cell lysis buffer) 
To harvest the cells, the medium was discarded and the cells were washed once 
with PBS. The cells were scraped off from the plate and resuspended in the residual 
PBS. The suspension was transferred into a microfuge tube. Another 1 mJ of PBS 
was added to the plate and the residual cells were scraped off. The suspension was 
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again transferred to the same microftige tube and centrifuged at 13,000 rpm in a 
desktop centrifuge for 30 s; the supernatant was discarded. The cell pellet was 
resuspended with three pellet-volumes of cell lysis buffer supplemented with 
protease inhibitors mixture and incubated on ice for 30 min. To get rid of the cell 
debris, the resuspension was centrifuged at 13,000 rpm in a desktop centrifuge for 30 
min at 4°C. The supernatant was saved and transferred to a new microflige tube. 
The protein concentration of the lysate was measured as described above. For 
confirmation of expression of expected proteins, the lysate was analyzed by 
SDS-PAGE followed by Western blot. 
XRE-luciferase gene reporter assay 
Transient transfection of cell using lipofectamine PLUS reagent 
MCF-7 cells were seeded at 10^ cells/well in 24-well plates. After 24 h, the cells 
were transiently transfected with 4.0 jxg of the XRE reporter plasmid and 1.0 jig of 
renilla luciferase control vector pRL (Promega, Madison, WI, USA) in 
lipofectAmine PLUS (Invitrogen Life Technologies) as described in the manual. 
After 16 h, the transfection medium was removed and 1ml of fresh medium was 
added to each well. Cells were then treated with 1 |iM DMBA and various 
concentrations of phytochemicals for 24 h. The amounts of these two luciferases 
were determined using Dual-Luciferase Assay Kit (Promega). 
Dual Luciferase Assay 
Dual Luciferase assays were preformed according to the manual (Promega). 20 
|il cell lysate was mixed with 50 jil of reaction buffer supplemented with firefly 
luciferase substrate. The luciferase bioluminescence was measured by using a 
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FLUOstar Galaxy plate reader. The XRE transactivation activities represented by 
firefly luciferase light units were then normalized with that of renilla luciferase. 
Manipulation of DNA and RNA 
Separation and purification of DNA from agarose gel 
Different percentages of agarose gels (typically 1.0% or 2.0%, w/v) were 
prepared with TAB buffer containing 0.4 |ig/ml of ethidium bromide. DNA samples 
were loaded on the gel immersed in TAB buffer and separated at 70V for 45 min; 1 
kb marker or 100 bp marker was used as size reference. The bands of interest were 
cut out from the gel and purified with the CONCERT™ Rapid Gel Extraction 
Systems (Gibco BRL). 30 |il of Gel Solubility Buffer (LI) was added for every 10 
mg of gel in a 1.5-ml microtube at 50°C to allow complete dissolve. The mixture was 
then transfer to a cartridge on the top of a 2-ml wash tube and centrifuged at 13,000 
rpm in a desktop centrifuge for 1 min. The solution in the collection tube was 
discarded; 0.7 ml Wash Buffer was added to the cartridge which was then incubated 
at room temperature for 3 min and centrifuged as above. The cartridge-collection 
tube assembly was centrifuged for further 1 min to remove the residual wash buffer. 
The DNA was eluted with 40 |LI1 of MQ water and collected by centrifugation into a 
new clean microtube. The eluted DNA was stored at -20° C or used immediately. 
Separation of DNA from acrylamide gel 
The DNA samples in loading buffer were separated on 10% polyacrylamide gel. 
The apparatus (Mini-PROTEAN HI, BioRad) and power supply (Power Pac 200/ 
1000/ 3000, BioRad) used for running protein samples were products from BioRad. 
The 8% polyacrylamide gel mix (5 ml) was prepared by mixing 1.33 ml of 30% 
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acrylamide together with 2.7 ml MQ water, 1 ml 5X TBE 0.4 ml APS and 4 |LI1 of 
TEMED. The DNA samples were then loaded on the wells and voltage (usually 200 
V or lower) was applied to the buffer. The DNA bands were visualized by straining 
the gel with TBE containing 0.5 |ig/ml of ethidium bromide for 15 min. 
Restriction digestion 
Restriction digest was used to prepare DNA inserts for subcloning or for 
confirmation of transformants. To prepare DNA inserts, 5 jig of plasmid DNA was 
used and the total reaction volume was 50 |al. To confirm transformants, 1 |Lig 
plasmid DNA was used and the total reaction volume was 15 |il. All restriction 
enzymes and the respective lOx buffers were products from New England BioLabs. 
Plasmid DNA was mixed with restriction enzymes (1 or 0.1 unit each) and lOX 
buffers (5 or 1.5 |LI1); then the volume was brought to 50 or 15 |LI1 by MQ water. All 
the reactions were incubated in a 37°C water bath for 2 h unless instructed otherwise 
by the manufacturer. 
Ligation of DNA fragments 
The T4 ligase (400 unit/ |al) and lOx T4 ligase buffer used in all ligation 
reaction were products from NEB unless stated otherwise. The DNA insert and 
vector were mixed at a 3:1 concentration ratio (determined by resolving them on 
agarose gel), with 2 of lOx T4 ligase buffer and 400 units of T4 ligase (one unit 
being defined as the amount of enzyme required to give 50% ligation of Hind HI 
fragments of Lambda DNA in 30 min at 16°C in 20 |il and a 5' DNA termini 
concentration of 0.12 |iM). The volume was brought up to 20 |il with MQ water. 
The reaction was incubated at room temperature for 2 hrs or at 16°C for 16 h. Then 
the ligation product was then stored at -20°C or used immediately for transformation. 
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IVansformation of DH5a 
The whole ligation mix or 1 |Lig of plasmid DNA was transferred into a 1.5-ml 
raicrotube containing 200 |il of competent DH5a or BL21(DE3) cells and left on ice 
for 30 min. The cells were placed into 42°C water bath for 1.5 min for heat shock and 
chilled on ice for 3 min for cold shock. The transformation mix was mixed with 1 
ml of LB medium and incubated at 37°C in a shaker for 30 min. The mixture was 
then centrifuged at 1,000 rpm in a desktop centrifuge for 5 s，and 900 |LI1 of the 
supernatant was discarded. The pellet was resuspended in the residual medium and 
plated on LB^^ plate and incubated at 37°C overnight. Transformants that grew on 
plate as single colonies were transferred into 2 ml of LB咖P medium with toothpicks 
and incubated at 37°C with shaking overnight. The cultures were screened by PCR 
with appropriate primers and analyzed with agarose gel electrophoresis. 
Transformants that scored positive with the PCR screening were further analyzed by 
restriction digest after mini-prep. One of the transformants was then inoculated into 
200 or 500 ml of LB^^ medium and grew with shaking at 37°C overnight. 
Large-scale plasmid isolation (maxi- or giga-prep) was then performed. 
Small scale plasmid purification from DH5a (mini prep) 
A single colony of transformed DH5a on a LB細p plate was inoculated into 2 ml 
of LB^P medium at 37 °C with shaking overnight. The overnight culture was 
transferred into a microtube and pelleted; the supernatant was discarded. Plasmids 
were purified by QIAGEN Plasmid-Prep Kit. 100 |il of PI buffer was added into the 
microtube，followed by vortexing. The suspension was then mixed with 100 |LI1 of 
P2 and incubated at room temperature for 10 min to lyse the cells. P3 (100 fil) was 
then added and the lysate was incubated at 4 � C for 5 mm to neutralize the lysates. 
The lysate mixture was centrifuged at 4°C and 13,000 rpm in a desktop centrifuge for 
19 
• CHAPTER 2 
10 min. The supernatant was then transferred to a new microtube and the plasmid 
DNA was purified by resins inside a column. 
Large scale plasmid isolation from DH5a (maxi-prep) 
QIAGEN Plasmid Maxi kits were used to prepare plasmid DNA at large scale. 
An overnight culture of transformed DH5a (500 ml of LB她was transferred into a 
500-ml conical tube and centrifuged at 6000 g for 10 minutes. The supernatant was 
discarded and the pellet was resuspended in 10 ml of PI solution. 10 ml of P2 
solution was applied to the resuspended culture and incubated at room temperature 
for 5 minutes. To neutralize the lysate, 10 ml of P3 solution was pipetted into the 
lysate, followed by incubation on ice for 10 minutes. The cell debris was separated 
from the plasmid DNA by centrifugation in a 30-ml centrifuge tube at 13 k rpm in a 
desktop centrifuge for 30 minutes. To further remove the debris, the supernatant 
containing the plasmid DNA was transferred to a new 30-ml centrifuge tube and 
centrifuged for further 30 minutes. QBT solution was added to the maxi- prep 
column to activate the resin at the bottom of the column. After all the QBT has gone 
through the column, the cell lysate from above was pour into the column until all of 
the lysate has eluted out. To wash the resin, one column volume of QC solution 
was added to the column twice. To elute the DNA from the resin, the column was 
assembled to a 15-ml centrifuge tube containing 15 ml of 100% isopropanol; then 15 
ml of QF solution was added to the column. The eluant was mixed with the 
isopropanol by inversion. To precipitate the DNA, the solution was centrifuged at 
10,000 g for 45 minutes; then the supernatant was discarded and the pellet was dried 
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Construction of XRE activated luciferase reporter gene 
A fragment with five XRE elements from rat CYPlAl 5'-flanking region was 
amplified using primers (XRE FOR and XRE REV) specific for rat genomic DNA as 
described by Backlund et al. (1997). No other response elements were identified in 
厂 
this fragment. The PGR product was digested with Smal and BamHI and subcloned 
into a firefly luciferase reporter vector pTA-Luc (Clontech, Palo Alto, CA, USA). 
Measurement of DMBA-DNA adduct formation 
This assay was performed as previously described (Ciolino et al., 1999). MCF-7 
cells were plated in 6-well plates at 5x10^ cells per well and allowed to attached for 
24 h. Then 0.1 (xg/ml of [^H]-DMBA (Amersham, Arlington Height, DL, USA) was 
administered with or without phytochemicals. After 16 h, cells were washed twice 
with cold phosphate-buffered saline (PBS), trypsinized and pelleted. Nuclei were 
separated by incubating the cells for 10 min on ice in lysis buffer A (10 mM 
Tris-HCl, pH7.5, 320 mM sucrose, 5mM magnesium chloride and 1 % Triton X-100). 
The nuclei were collected by centrifugation at 5000 rpm for 10 min at 4°C after the 
incubation. The nuclei were then lysed by 400 |xl lysis buffer B (1 % sodium dodecyl 
sulphate (SDS) in 0.5 M Tris. 20 mM EDTA and 10 mM NaCl, pH 9), followed by 
the treatment of 20 \d 20 mg / ml Proteinase K for 2 h at 48�C. After that, the 
samples were allowed to cool to room temperature and the residual protein was 
salted out by adding 150 |il of saturated NaCl. The samples were then subjected to 
centrifugation at 13,000 rpm for 30 min at 4°C. Genomic DNA was isolated from 
supernatant by ethanol precipitation, and redissolved in MQ water. Absorbance at 
260 nm and 280 nm were employed to determine the amount and purity of the 
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Semi-quantitative RT-PCR Assay 
Isolation of RNA using TRIzol® Reagent(Life Technology,US A) 
Total RNA was isolated from cells grown in 6-well Costar plates in triplicates 
by Trizol Reagent as described by the manufacturers (Life Technology, USA). Cells 
were washed with cold PBS twice. 1 ml of TRIzol reagent was added in each well 
and aspirated for several times to lyse the cells. The homogenous sample was 
incubated at room temperature for 5 min and transferred to a microtube. 0.2 ml of 
chloroform was added. Then the sample was mixed vigorously by shaking for 15 s 
and was allowed to stand at R.T. for 3 min. The sample was then subjected to a 
centrifugation at 12 000 g for 15.min at 4�C. Afterward, the upper aqueous layer was 
transferred to a new microtube containing 0.5 ml isopropanol. The sample was 
incubated at room temperature for another 10 min and centrifuged at 12 000 g for 10 
min at 4°C. The supernatant was removed and the RNA pellet was mixed with 1 ml 
of 75 % ethanol. Then the RNA was re-pelleted and air-dried. 30 |Lil of DEPC water 
was added to redissolve the RNA which was then stored at —80�C. The amount and 
purity of RNA were determined by measuring its absorbance at 260nm and 280nm. 
The amount was calculated by the formula: OD260 * 40 mg ml'^  = Amount of RNA 
(mg ml-i). RNA isolated by this method exhibited a 260/280 ratio of > 1.6. 
RT-PCR 
A reverse transcription-polymerase chain reaction (RT-PCR) assay was used to 
quantitate mRNA level. 5 |LLg of RNA was used for cDNA synthesis, and the final 
volume was diluted to 20 |iL Primers of CYPlAl, CYPIBI and p-actin, sequences 
as published formerly (Dohr et al.,1995) and a Perkin Elmer Thennocycler 
(GeneAmp PGR System 2400) was utilized to amplify the target cDNAs separately 
after the first strand reaction. All PGR reactions consisted of 0.2 mmol/L dNTP, 2 |Lil 
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cDNA, 0.2 |imol/L of each primer, IxPCR buffer and 1 U of Taq polymerase. The 
conditions were 9代 for 45 s，65T for 45 s, 7 2 T for 1 min, and a final extension 
period of 7 min at 72T . The amplification cycles were 25 for CYPlAl，23 for 
CYPIBI, and 19 for P-actin. The PGR products were separated on 2% agarose gel, 
stained with ethidium bromide, and photographed. A scanner equipped with Scion 
Image software (Scion Corporation, Frederick, MD, U.S.A.) was used to compare the 
optical density of the amplified fragments. The linearity of signals was verified in 
separate experiments. 
Enzyme Activities 
Isolation of microsomes 
MCF-7 cells were treated with 1 i^M of DMBA to induce CYPlAl and IBl 
activities. After 24 h these cells were trypsinized, centrifuged at 1000 rpm for 5 min 
at 4�C. The cells were then suspended in storage buffer (10 mM Tris-HCl, 0.25 M 
sucrose, pH 7.5, with 100 (ig/ml phenylmethylsulphonylfluoride, 300 pg/ml EDTA, 
0.5 jxg/ml leupeptin, 0.5 (xg/ml aprotinin 0.7 |xg/ml Pepstatin A), and sonicated on ice 
for 30s. The lysate was centrifuged at 5,000 rpm for 15 min, and the supernatant was 
collected and centrifuged again at 45,000 rpm for 30 min at 4�C. The microsomal 
pellet was resuspended in the storage buffer, aliquoted and stored at -80°C. The 
concentration of microsomal protein was determined by a Bradford-based BioRad 
protein assay as described above. 
EROD activities in intact cells 
The assay method was performed as previously described (Cholino et al., 1999). 
In brief, MCF-7 cells in 96-well were treated with 1 jjM DMBA and various 
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concentration of phytochemicals. The medium was then removed and the cells were 
washed twice by 100 (xl PBS. Ethoxyresorufin-O-deethylase (EROD) activities, 
which are indicatives of CYPl Al and CYPIBI, were then carried out 50 |il of 5 _ 
ethoxyresorufm (ER) in PBS with 1.5 mM salicyclamide was added in each well, and 
incubated at 37�C for 15 min. The reaction was stopped by 50 jil of ice-cold 
methanol, and the resomfm generated was measured by a FLUOstar Galaxy 
microplate reader (BMG LabtCQhnologies, Offenburg，Germany) with an excitation 
of 544 nm and emission at 590 iim. The activities were quantitated against resomfm 
standards. 
EROD inhibition assay 
A reaction mixture containing 10 \ig microsomal protein, or 1.6 pmol human 
recombinant CYPlAl，or 2 pmol CYPIBI was incubated in 100 |il PBS, pH 7.2 with 
400 nM ER/MR and phytochemicals in different concentrations. The reaction was 
initiated by 500 joM NADPH, and stopped by 100 (ol of ice-cold methanol. After 15 
min of incubation, the fluorescence was measured as described above. 
To determine the kinetic of CYPl enzyme inhibition, 280 |il of 125 - 1600 nM 
ER/MR were prepared in the presence of various concentrations of drugs. Three 80 
\A of aliquots of each (yielding final concentration of lOOnM — 1600 nM) was placed 
in a 96-weU plate and the reaction was initiated by the addition of 20 |LI1 of 2500 |iM 
of N A D P H (final concentration 500 |LLM) and 10 |xg microsomes per well. After 15 
min, 100 \i\ of methanol was added and the reaction was assayed as above. 
Statistical Analysis 
A Prism® 3.0 software package (GraphPad Software, Inc., CA, U.S.A) was 
utilized for statistical analysis. The results, whenever applicable, were analyzed by 
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One-way ANOVA followed by Bonferroni's Multiple Comparison Test if significant 
differences (p<0.05) were observed. T-test was also performed to compare the cell 
cytotoxicity between DMBA-treated samples and those sauries treated with DMBA 
plus phytochemicals. 
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CHAPTER 3 BAICALEIN INHIBITS D M B A - D N A 
ADDUCT FORMATION BY MODULATING CYPlAl AND 
IBL ACTIVITIES 
Introduction 
Baicalein is a flavone isolated from the root of Scutellariae radix 黃夸.(Figure 
3.1) The flavonoid is present in the popular Japanese herbal mixture Sho-saiko-to, 
which is widely used for the treatment of liver disease and carcinoma. In China, it 
has been used for thousands of years for curing inflammatory diseases and 
hypertension. Baicalein has been demonstrated to possess antiproliferative activity 
on prostate cancer cells (Chen et al., 2001), hepatoma cells (Motoo et al , 1994), 
vascular smooth muscle cells (Huang et al., 1994), etc. Baicalein has also been 
described as an antioxidant (Chen et al., 2000), anti-inflammatory agent (Lin et al.， 
1996), and an inhibitor to prostaglandin E2 (Nakahata et al., 1998). Previous animal 
studies have demonstrated the modulating effects of baicalein on CYPlAl enzyme in 
mice (Ueng et al., 2000) while Kim et al. (2002) suggested that baicalein might 
protect the liver through the inhibition of CYPIA2-mediated procarcinogens 
activation. However, the possible role of baicalein on CYPl enzymes and carcinogen 
induced DNA damage still remains unclear. 
In this study, we investigated the effects of baicalein on DMBA-induced AhR 
transactivation，CYPl enzymes activities and induction. Our hypothesis was that 
baicalein could reduce DMBA-DNA adduct formation by modulating the 
biotransformation enzyme activities. 
26 
• CHAPTER 2 
圓 f 
Figure 3.1 Picture of Scutellariae radix and the structure of baicalein. 
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Results 
EROD activities in M C F - 7 cells and inhibition assay 
EROD activities could be the indicatives of CYPlAl and CYPIBI. The 
significance of both CYP enzymes has been implicated in chemical carcinogenesis in 
recent researches. EROD activities in intact cells that had been exposed to 1 |LIM 
DMBA in the presence of baicalein for 24 h were measured. DMBA-induced EROD 
activities in cell cultures were reduced by baicalein in a dose-dependent manner. The 
IC50 was around 1 |iM as shown in Figure 3.2 To further explore the inhibition 
mechanism for baicalein, microsomal EROD activity with or without baicalein was 
measured in a different substrate concentration and the kinetics of enzymes inhibition 
by baicalein were analyzed by double-reciprocal (Lineweaver-Burk) analysis (Figure 
3.3) Baicalein was proved to be a competitive inhibitor of EROD with an apparent IQ 
of 0.54 |iM. These results showed that baicalein could modulate the EROD activities 
induced by DMBA at the enzyme level, and the biotransformation of DMBA could 
be affected by the reduced enzyme activities. 
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Figure 3.2 Baicalein inhibited DMBA-induced EROD activity in MCF-7 
cells. 
MCF-7 cells were seeded in 96-well culture plates and treated with 1 jiM DMBA and 
various concentrations of baicalein. After 24 h of treatment, cells were assayed for 
EROD activity as described. The estimated EC50 value is 0.97 |uM, and the values are 
means 士SE，n=6. 
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Figure 3.3 Baicalein competitively inhibited microsomal EROD activity. 
MCF-7 cells were cultured in T-75 flasks and treated with 1 [iM DMBA. After 24 h 
of treatment, microsomes were isolated and used for enzyme kinetic study. (A) 
EROD activity in 10 |lg of microsomes was measured in the presence of 400nM ER 
and the indicated concentration of baicalein.. Values are means 土SE，n=3. (B) Lines 
shown were determined by linear regression of the reciprocal data. Inset, rep lot of the 
slopes obtained by linear regression of data from the Lineaweaver-Burk plot, with 
derivation of Ki Values shown here are mean 土SE, n=3. 
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Baicalein suppressed DMBA-induced XRE-driven luciferase activities. 
Many studies indicate that some phytochemicals can compete with xenobiotics 
for Ah receptor binding (Ashida et al., 2000; Lee et al., 2000; Christopher et al.， 
2001). Because the DNA-binding domain of the activated receptor recognized XRE 
sequence, this transient transfection assay could signal the receptor status. Baicalein, 
by itself, was a weak agonist for XRE binding at 1 |xM, but the agonistic activities 
were not seen at the other concentrations tested (Figure 3.4). On the other hand, 
DMBA could induce the luciferase activities by 4.2 folds as shown in Figure 3.5, and 
the luciferase activity was reduced in a dose dependent manner when baicalein was 
co-administered in the cultures. This indicated that the DMBA-induced XRE 
transactivation activities could be suppressed by baicalein. Gene promoters that 
contained XRE regions, such as CYPlAl and CYPIBI, could be affected by 
baicalein treatment. 
Baicalein inhibited DMBA-induced CYPlAl and CYPIBI mRNA expression 
As the XRE transactivation activities were repressed by baicalein, the mRNA 
expressions of CYPlAl and CYPIBI were studied. The RT-PCR results as 
illustrated in Figure 3.6A indicated a dose dependent decline in both CYPlAl and 
CYPIBI expressions. The optical density readings (Figure 3.6B & 3.6C) showed 4.5 
and 2.6 fold increase in CYPlAl and CYPIBI expressions in cells treated with 1 
jlM DMBA, and significant (P<0.05) inhibitions were seen at 5 and 10 [iM of 
baicalein in CYPlAl and CYPIBI expressions, respectively. CYPlAl expression 
appeared to be more responsive than that of CYPIBI. 
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Figure 3.4 Effect of baicalein on XRE-driven luciferase activities. 
MCF-7 cells were transient transfected with XRE-Luc reporter plasmids, and treated 
with baicalein at concentrations of 0，1,5，10, and 20 ！iM for 24 h. Values are means 
±SEM, n=3. Means marked (*) significantly (P<0.05) differ from control (0 |iM). 
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Figure 3.5 Effect of baicalein on DMBA-induced XRE-driven luciferase 
activities. 
MCF-7 cells were transient transfected with XRE-Luc reporter plasmids, and treated 
with 1 JOM D M B A and baicalein at concentrations of 0，1，5，10, and 20 |LIM for 24 h. 
Values are means 土SEM，n=3. Means with different letters differ (P<0.05). 
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Figure 3.6 The influences of baicalein on mRNA abundance of CYPlAl 
and CYPIBI 
MCF-7 cells were seeded in 6-well culture plates and treated with 1 jiM DMBA and 
DMSO (control) or various concentrations of baicalein for 24 h. Total RNA was then 
isolated and semi-quantitative RT-PCR was used to determine the relative mRNA 
expressions. Figure 5.7A is the gel image of the ethidium bromide-stained PGR 
fragments. Figure 3.6B and C were optical density results of the CYPlAl and 
CYPIBI fragments from RT-PCR. Values are means 土SEM，n=3. Means with 
different letters differ (P<0.05). 
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The cytotoxic effect of DMBA was reduced by baicalein 
The metabolites of DMBA were genotoxic agents that could induce death to the 
MCF-7 cells in a span of 72 h. At all the concentrations tested, the percentage of cell 
survival was significantly lower than the control as shown in Figure 3.7 Baicalein 
administered at 2.5 jilM could reverse some of the damages done to the MCF-7 cells 
by DMBA. By itself, 24-h baicalein treatment was not cytotoxic to the cultures until 
the concentration reached 50 [iM (Figure 3.8). 
Inhibition of DMBA-DNA adduct formation after baicalein treatment 
Because of the inhibition at the enzyme as well as at the expression levels of 
CYPlAl and CYPIBI, the ultimate carcinogenic form of DMBA might be affected. 
Figure 3.9 illustrated that a dose-response decrease was observed in the 
DMBA-DNA adduct formation in MCF-7 cells treated with baicalein. 1 jxM 
baicalein could reduce the adduct formation by 20%, and 70% by 5 |LLM. 
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Figure 3.7 Cytotoxicity of DMBA and baicalein co-treatment. 
M C F - 7 cells were cultured in 96-well plates. D M B A ranged from 0 to 1 |LIM was 
added to the cultures, and 0 |LLM (Control) or 2.5 |LLM baicalein was co-administered 
with DMBA. After 72 h of treatment, the cell viability percentage was assayed by 
MTT. Values are means 土SE，n=3. Means marked (*) are significantly (*P<0.05) 
lower than the control; means of co-treatment marked (a) are higher than the means 
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Figure 3.8 The cytotoxic effect of baicalein alone on MCF-7 cells. 
MCF-7 cells were cultured in 96-wells plate and baicalein ranged from 0 to 100 |LIM 
was added to the cultures. After 24 h of treatment, the cell viability percentage was 
assayed. Values are means 土SE，n=3. Means marked (*) are significantly (*P<0.05) 
lower than the control. 
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Figure 3.9 DMBA-DNA adduct formation in MCF-7 cells after baicalein 
treatment. 
MCF-7 cells were cultured in 6-well plates and treated with tritiated DMBA in 0.1 
|ig/ml and one of four baicalein concentrations, 0，1,5，10 |iM, was co-administered. 
After 16 h of treatment, genomic DNA was isolated and the DMBA-DNA lesions 
were determined by scintillation counting. Values are means 土SE，n=3. Means 
marked (*，significantly (*P<0.05, **P<0.001) differ from control (0 |iM). 
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Discussion 
In this study, we demonstrated that baicalein reduced DMBA-DNA adduct 
formation in the breast cancer cell line MCF-7. The mechanism was related to the 
inhibition of CYPlAl and CYPIBI enzyme activities and gene expressions. EROD, 
the indicative of CYPlAl and CYPIBI, was competitively inhibited by baicalein as 
shown in the enzyme kinetic study. In addition, the mRNA expressions of CYPlAl 
and IBl induced by DMBA were also suppressed by baicalein. Previous studies have 
shown that AhR ligands, such as PAHs, can induce both CYPs (Lusska et al., 1992; 
Alexander et al., 1997). Our XRE-transfection results indicated that the suppression 
of mRNA expressions could have occurred in the interruption of Ah receptor 
transactivation. The overall DMBA-induced EROD activities in cell cultures, which 
were significantly reduced by baicalein at submicromolar concentrations, could be 
due to enzyme inhibition and decreased expression. 
This study demonstrated baicalein inhibited xenobiotic-induced EROD 
activities in MCF-7 cells. By contrast, an animal study has shown that baicalein 
induces EROD activities in mouse lung without affecting EROD activities in the 
liver (Ueng et al., 2000). The difference between this and our study is that PAH is 
not administered in this rat study. Moreover, the tissue distribution and species 
variation may also account for the differences. The same research group uses the 
same model and demonstrates that baicalein prevents DNA damage caused by 
benzo[a]pyrene and aflatoxin B-1 (Ueng et al., 2001). Although the roles of CYPlAl 
and CYPIBI have not been addressed, the results of this animal study illustrates that 
baicalein can modulate the PAH metabolism. Since many XRE sites have been 
identified in the 5'-flanking regions in the human as well as rat CYPlAl and 
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CYPIBI promoters, the interruption of AhR transactivation can affect the gene 
expressions (Tang et al., 1996; Corchero et al., 2001). Our study verified that 
baicalein decreased the expressions of CYPlAl and CYP IB 1，through the 
interruption of AhR transactivation. 
Many phytochemicals affects CYPlAl either at the mRNA or enzyme level， 
or both. The flavonoid galangin (Ciolino et al.，1999)，curcumin (Ciolino et al., 1998) 
and quercetin (Ciolino et al.，1999) are ligands of AhR. They can stimulate CYPlAl 
mRNA expression by themselves, but they also inhibit the same expression induced 
by DMBA. Similar effects at the enzyme level are also observed. Kaempferol 
(Ciolino et al.，1999) and resveratrol (Ciolino et al., 1999)，on the other hand, reduce 
PAH-induced CYPlAl mRNA, but they are not AhR ligands. In current study, we 
demonstrated that baicalein was an inhibitor of EROD and a modulator of CYPlAl 
as well as CYPIBI expressions. Baicalein appeared to be a weak agonist to AhR 
because of the weak induction of EROD activities and XRE driven luciferase 
activities when administered alone. As suggested by Ciolino et al. (1999) individual 
flavonoid might have differential effects on the CYP protein at the enzyme and 
expression levels. 
In summary, we demonstrated that DMBA-DNA adduct formation in the 
breast cancer cells MCF-7 was reduced by baicalein. The mechanisms by which 
these DNA lesions were decreased might be mediated through the modulation of 
CYPlAl and IBl gene expressions and enzyme inhibitions. 
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FORMATION BY (-)-EPIGALLOCATECHIN GALLATE 
AND THEAFLAVINS 
INTRODUCTION 
Tea, an extract of the leaves of the plant Camellia sinensis has long been 
considered as a healthy beverage worldwide. Epidemiological and experimental 
studies have demonstrated that tea diminishes cancer risk in breast, lung, esophagus, 
colon and skin (See reviews on Dreosti et al., 1997; Katiyar et al.，1997; Yang et al., 
2001, 2002); Although green tea has shown chemopreventive properties, black tea 
also inhibits carcinogenesis with lower effectiveness than green tea in some studies. 
They inhibit tumorigenesis at the initiation, promotion, and progression stages in 
different animal models. The chemopreventive effects of tea have been attributed to 
the biological activities of tea polyphenolics. 
Being a major polyphenol in green tea, (-)-epigallocatechin gallate (EGCG) 
possesses higher anti-proliferative, anti-neoplastic，and anti-mutagenic activities in 
numerous models than other green tea polyphenols including (-)-epicatechin (EC)， 
(-)-epicatechin gallate (EGC) (Liang et al.，1999; Ahmad et al., 1998; Mukhtar and 
Ahmad, 1999). EGCG inhibits 4-(methylnitrosamino)-1 -(3-pyridyl)-1 -butanone 
(NNK) -induced lung tumors (Xu et al, 1992)，7,12-Dimethylbenz[a]anthracene 
(DMBA) induced-breast cancer (Kavanagh et al.，2001), and azoxymethane (AOM)-
induced colon cancer (Ohishi et al., 2002). These indicate that EGCG exhibits 
protective effects against chemical induced carcinogenesis. Also, a reduction of 
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carcinogen-DNA adduct formation has been observed with human DNA in the 
presence of EGCG (Katiyar et al., 1992; Wang et al.，1989). Studies have 
demonstrated that EGCG can intervene the biotransformation of carcinogens by 
modulating some enzyme activities. Induction of phase U enzymes such as 
glutathione-S-transferase and NAD(P)H:quinone reductase (QR) is enhanced by 
EGCG and the removal of activated carcinogens is sped up (Stoner et al., 1998; Chou 
et al.，2000; Katiyar et al.，1993). Researches have shown that EGCG also modulates 
P450 enzymes activities and reduces ultimate carcinogen formation (Xu et al., 1999). 
CYPl enzymes transform carcinogen that attack DNA and cause mutation. EGCG 
suppresses the AhR-mediated transcription of CYPl A gene expression and CYPl A 
enzyme activities, and toxicity of chemical carcinogens can be reduced (Williams et 
al., 2000). It is interesting to note that other green tea polyphenols act synergistically 
on the anticancer activities of EGCG but the mechanisms are still unclear (Suganuma 
et al.，1999; WilHams et al., 2000). 
The typical polyphenols in black tea are theaflavins: TFl, TF2A, TF2B and TF3. 
(Figure 4.1) Although theaflavins also exhibit anti-carcinogenesis effects in different 
models, little is known about their chemoprevention mechanism compared with that 
of green tea. Theaflavins inhibit neoplastic transformation in human lung cells 
(Sazuka et al., 1997), mammary cells and rat tracheal epithelial cells (Steele et al.’ 
2000). Similar to green tea polyphenols, they are strong antioxidants that are capable 
of inhibiting DNA-carcinogen lesions (Leung et al., 2001; Schut et al., 2000). Some 
researches have suggested that theaflavins may play a role in modulating carcinogens 
activation (Apostolides et al., 1997). Benzo[a]pyrene metabolism is inhibited in the 
presence of black tea in rat liver microsomes (Hammons et al., 1999). Steele et al. 
(2000) show that the inhibition of free radical formation rather than the phase II 
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isozyme induction contributes to the protective mechanism of theaflavins against the 
development of tumors in vitro. On the other hand, Feng et al. (2002) showed that 
theaflavins inhibit omeprazole (OME)-induced CYPlAl expression. Instead of 
inducing CYPlAl by the AhR cascade, OME upregulates CYPlAl from 
kinase-mediated signal transduction pathway. Thus, the protective role of theaflavins 
may partly arise from their ability to inhibit the formation of activated carcinogens. 
In the present study, we have investigated the effects of theaflavins on 
DMBA-induced DNA-adduct formation in the mammary cancer cell line MCF-7. 
Also, the possible role of theaflavins on AhR mediated CYPl enzyme expression and 
activities was studied. 
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Figure 4.1 Chemical structures of theaflavins and EGCG. 
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RESULTS 
Persistence of DMBA-induced DNA adducts 
The anticarcinogenic effects of theaflavins and EGCG have been demonstrated 
in rats and various cell models. Nevertheless, their effects on DMBA-DNA adduct 
formation in mammalian cell culture remain unknown. To explore their effects on 
DMBA toxicity, 1 jiig/ml [^H] DMBA was added to MCF-7 cells seeded in 6-well 
plate for 16h in the presence of various concentration of theaflavins and EGCG. 
Genomic DNA was then isolated and subjected to scintillation counting. Among the 
4 theaflavins, TF2A was the most effective agents that suppressed approximately 
50% of DMBA-DNA adduct formation at a concentration of 50 jiM (Figure 4.2). 
Nevertheless, TFl at 50 |iM suppressed only 30% of DMBA-DNA adduct formation. 
EGCG showed a 20 % reduction in DMBA-DNA adduct formation at 10 |iM, while 
EGC and EC did not have significant effects (Figure 4.3). 
45 
• CHAPTER 2 
140 -r 
^ 120 -- J 
I | i � - -I I I g i i i y L H i ^ 
1 1 s o - 圖 _ _ * * fi * * 圓 圏 * * 
Q cO £ i 1 i T T I 1 I I x 足 1 1 - 丨 11 i i r y I I I • “ - - I i 11 i i l l l l i 
它 發 教 頻 髮 ⑤ 圏 圏 _ _ 圖 W 20-- _ _ _ _ _ _ _ _ _ _ " _ _ _ _ _ I , I I I , 
0 I • i關i翻I關I翻I關11:: M I M I M I圓丨丨1 I丨I丨丨丨I丨丨丨丨丨丨糊I _ I _ I糊I麟I 
C I 5 10 25 50 1 5 10 25 50 1 5 10 25 50 1 5 10 25 50 I II II 1 I 1 ^ TO TF2A TF2B TO ^ 
1 I^M DMBA + [Theaflavin] |LIM 
Figure 4.2 Pattern of DMBA-DNA adduct formation in MCF-7 cells 
treated with theaflavins. 
MCF-7 cells were cultured in 6-well plates and treated with tritiated DMBA in 
0.1 |ig/ml and one of six theaflavins concentrations, 0，1，5, 10，25, 50 |LIM, was 
co-administered. After 16 h of treatment, genomic DNA was isolated and the 
DMBA-DNA lesions were determined by scintillation counting. Values are means 
土SE，n=3. Means marked (*, **) significantly (*P<0.05, **P<0.001) differ from 
control (0 piM). 
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Figure 4.3 EGCG suppressed DMBA-DNA adduct formation. 
The effect of green tea polyphenols on DMBA-DNA adduct formation was assayed 
as described in figure 3.6. Values are means 土SE, n=3. Means marked (*) 
significantly (*P<0.05) differ from control (0 fiM). 
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Inhibition of theaflavins and EGCG on human recombinant CYPlAl and 
CYPIBI enzyme activities 
As EGC and EC did not modulate DMBA-DNA adduct formation, we focused 
on EGCG and theaflavins only in the following experiments. To investigate their 
effects on the catalytic activities of CYPlAl and CYPIBI, enzyme kinetic assays 
were carried out with recombinant enzymes and various concentrations of theaflavins 
and EGCG (Figure 4.4). It was found that inhibitory effects of the 4 theaflavins on 
CYPlAl and CYPIBI enzymes were stronger than that of EGCG. Among the 4 
theaflavins, TF2B seemed to be the most effective in the inhibition of recombinant 
CYPlAl and CYPIBI activities. 
EGCG suppressed DMBA-induced EROD activity while thealfavin had no 
significant effect on this 
Previous studies have demonstrated that phytochemicals may exert their 
anticarcinogenic effects by inhibiting DMBA-induced CYPl enzyme activities. 
Thus, we would like to investigate if theaflavins and EGCG could modulate the 
activities of CYPl enzymes after DMBA adminstration. MCF-7 cells were plated in 
96-well plate in the presence of 1 |iM DMBA and various concentrations of 
theaflavins or EGCG were administerd. EROD activity, an indicator for 
CYPlAl/ lBl enzyme activities was then measured after 24 h. Results showed that 
EGCG but not the 4 theaflavins had significant effects on DMBA-induced EROD 
activities (Figure 4.5) with an IC50 value of ~40 |xM (Figure 4.6). Moreover, EGCG 
alone caused slight increase on EROD activities in MCF-7 cells (Figure 4.7). 
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Figure 4.4 Effects of theaflavins and EGCG on recombinant CYPlAl and 
CYPIBI EROD activities 
EROD assay (400nM ER) was performed with 2.5 pmole of CYPlAl (A) and 2 
pmole of CYPIBI (B) enzymes and varying concentration of theaflavins and EGCG. 
The values are means 土SE, n二3. All values significantly differ (P >0.05) from the 
control (0 jxM). 
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Figure 4.5 Effects of theaflavins on DMBA-induced EROD activities 
MCF-7 cells were seeded in 96-well culture plates and treated with 1 juM DMBA and 
various concentrations of baicalein. After 24 h of treatment, cells were assayed for 
EROD activity as described. The values are means 士SE, n=6. The values at 40 juM 
for the four theaflavins are significantly differ (F >0.05) from the control (0 juM). 
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Figure 4.6 Effect of theaflavins on DMBA-induced EROD activities. 
The effect of EGCG on DMBA-induced activity was assayed as described in figure 
4.1. The values are means 士SE, n=6. All values are significantly different (P >0.05) 
form the control (0 |LIM). 
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Figure 4.7 EROD activities in MCF-7 cells treated with EGCG alone. 
MCF-7 cells were treated with 1 to 100 i^M of EGCG for 24 h. EROD activities were 
determined as described. The values are means 土SE, n=6. All data are significantly 
difference from the control (F< 0.05). 
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Kinetic analysis of EGCG on CYPlAl and CYPIBI activities 
As EGCG was shown to inhibit DMBA-induced CYPl enzymes in MCF-7 
cells, we would like to investigate it inhibitory pattern on CYPlAl and CYPIBI 
enzymes. Thus, kinetic analyses with recombinant CYPlAl and CYPIBI enzymes 
in the presence of various concentrations of ER and EGCG were carried out. Results 
showed that EGCG con^etitively inhibited CYPlAl enzyme with a Ki value of -20 
|LIM (Figure 4.8A). A mixed type inhibition was observed in CYPIBI activities and 
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Figure 4.8A Lineweaver-Burk plot of EGCG on CYPlAl enzymes 
inhibition. 
EROD assay was performed with human recombinant CYPlAl at indicated 
concentration of EGCG and 100-1600 nM ER as described under Material and 
Methods. Lineweaver-Burk plot were generated by linear regression of the reciprocal 
data. Inset, replot of the slopes from the Lineaweaver-Burk plot, with derivation of K 
which is equal to 18.34 |iMi. Values shown here are mean 土SE，n=3 . 
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Figure 4.8B Lineweaver-Burk plot of EGCG on CYPlAl enzymes 
inhibition. 
EROD assay was performed ‘ with human recombinant CYPIBI at indicated 
concentration of EGCG and 100-1600 nM ER as described in figure 4.5 A. Ki value 
is equal to 2.85 [iM. 
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Modulation of DMBA-induced XRE-driven luciferase activities by theaflavins 
and EGCG 
In addition to the evaluation of the effects of theaflavins and EGCG on 
DMBA-induced transcription of CYPl, XRE-driven luciferase reporter assay was 
also performed. This reporter assay signaled the transcription of CYPl and the 
adminstration of DMBA induced the luciferase activity by 3-fold as shown in figure 
4.6. Cotreatment with theaflavins had no effects on the induced luciferase activities 
(Figure 4.9A-C) except that TF3 caused an increase of activity (Figure 4.9D). By 
contrast, co-administration of EGCG resulted in a significant reduction of 
DMBA-induced luciferase activity (Figure 4.10). EGCG alone caused a slight but 
significant suppression at >2.5 |LLM (Figure 4 .11) . 
The influence of theaflavins and EGCG on CYPlAl and CYPIBI abundance 
To ftirther confirm the results from the transient transfection assay, RT-PCR 
were carried out to study CYPlAl and CYPIBI mRNA abundances. DMBA caused 
approximately 4-fold and 2-fold induction on CYPlAl and CYPIBI mRNA, 
respectively. The 4 theaflavins did not have significant effects on DMBA-induced 
CYPlAl and CYPIBI mRNA expressions (Figure 4.12-4.16). Nevertheless, all of 
them caused a slight induction on DMBA-induced CYPlAl mRNA expression at 20 
|iM. In contrast, EGCG caused a 25% reduction on the mRNA expression (Figure 
4.14). 
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Figure 4.9 Effects of theaflavins on DMBA-induced XRE-mediated CYPl 
transcription. 
MCF-7 cells were transient transfected with XRE-Luc reporter plasmid, and treated 
with 1 |iM DMBA and theaflavins: TFl (A), TF2A (B), TF2B (C) and TF3 (D) at 
concentrations of 0，1，5，10，25 and 50 |iM for 24 h. Values are means 土SEM, n=3. 
Means with different letters differ (P<0.05) from control (0 |iM). 
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Figure 4.10 Effect of EGCG on DMBA-induced XRE-mediated luciferase 
activity. 
The effect of EGCG on DMBA-induced XRE-driven luciferase activities was 
assayed as described. Values are means 土SEM，n=3. Means with different letters 
differ (P<0.05) from control (0 joM). 
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Figure 4.11 Effects of EGCG alone on XRE-driven luciferase activities. 
MCF-7 cells were transiently transfected with a luciferase reporter gene containing 
XRE and a pRL. Transfected cells were treated with 1, 5，10，25 and 50 |LLM of 
EGCG for 24 h. Firefly luciferase activities were normalized with renilla luciferase. 
Values are means 土S E M， n = 3 . Means without same letters differ (P<0.05). 
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Figure 4.12 CYPIAI/CYPIBI mRNA expressions in MCF-7 cells treated 
with TFl and DMBA. 
MCF-7 cells were seeded in 6-well culture plates and treated with 1 |iM DMBA and 
various concentrations of baicalein for 24 h. After 24 h of treatment, total RNA was 
isolated and semi-quantitative RT-PCR was used to determine the relative mRNA 
expressions. The upper panel is the gel image of the ethidium bromide-stained PGR 
fragments. The lower panel is the optical density results of the CYPlAl and 
CYPIBI fragments. 
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Figure 4.13 CYPIAI/CYPIBI mRNA expressions in MCF-7 cells treated 
with TF2A and DMBA. 
The effects of TF2A on CYPlAl and CYPIBI mRNA expression were assayed as 
described in figure 4.12. The upper panel is the gel image of the ethidium 
bromide-stained PGR fragments. The lower panel is the optical density results of the 
CYPlAl and CYPIBI fragments. 
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Figure 4.14 CYPIAI/CYPIBI mRNA expressions in MCF-7 cells treated 
with TF2B and DMBA. 
The effect of TF2B on CYPlAl and CYPIBI mRNA expression was assayed as 
described in figure 4.12. The upper panel is the gel image of the ethidium 
bromide-stained PCR fragments. The lower panel is the optical density results of the 
CYPlAl and CYPIBI fragments. 
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Figure 4.15 CYPIAI/CYPIBI mRNA expressions in MCF-7 cells treated 
with TF3 and DMBA. 
The effect of TF3 on CYPlAl and CYPIBI mRNA expression was assayed as 
described in figure 4.12. The upper panel is the gel image of the ethidiura 
bromide-stained PCR fragments. The lower panel is the optical density results of the 
CYPlAl and CYPIBI fragments. 
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Figure 4.16 DMBA-induced CYPlAl and CYPIBI mRNA expression were 
inhibited by EGCG cotreatment. 
The effect of EGCG on CYPlAl and CYPIBI mRNA expression was assayed as 
described in figure 4.12. The upper panel is the gel image of the ethidium 
bromide-stained PCR fragments. The lower panel is the optical density results of the 
CYPlAl and CYPIBI fragments. 
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Discussion 
The present study showed that theaflavins and EGCG inhibited DMBA-DNA 
adduct formation in MCF-7 cells, indicating that they may protect against chemical 
carcinogenesis because activated carcinogen-DNA adduct formation is correlated to 
a high risk of cancer (Hemminki, 2000). EGCG was shown to be more effective in 
preventing DMBA-DNA adduct formation than theaflavins. The protective 
properties of theaflavins against DMBA toxicity are TF2A> TF2B>=TF3> TFl. 
Many studies suggest that the chemoprotective effects of tea against 
PAH-induced mutagenesis are due to their abilities to modulate carcinogen 
metabolizing enzymes such as CYPl enzymes. Inhibition of CYPl enzymes may 
reduce the formation of activated carcinogens that leads to DNA damages. While 
numerous evidences show that green tea polyphenols inhibit carcinogens-induced 
CYPl enzyme expression, no conclusive result is obtained for the effects of black tea 
on P450 enzymes (Dashwood et al, 1999). Previous studies have demonstrated that 
green tea or black tea alone induced phase IP450 and phase n conjugating enzymes. 
Weisburger et al. (1998) report that black tea does not alter the amount of CYP2E1 
that is required for the activation metabolism of AOM. The present studies showed 
that both theaflavins and EGCG inhibited human recombinant CYPlAl and 
CYPIBI enzyme activities in vitro. Surprising, theaflavins had no significant effects 
on DMBA-induced CYPl activities in intact MCF-7 cells and this disagreed with the 
in vivo experiment. In contrast with theaflavins, EGCG was found to be capable to 
inhibit DMBA-induced CYPl activities. 
Certain phytochemicals have been demonstrated to affect AhR-mediated 
induction of CYPlAl. Resveratrol (Ciolino et al., 1998), quercetin (Ciolino et al., 
1999) and curcumin (Oetari et al., 1996) are naturally occurring ligands to the AhR 
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that produce either agonist or antagonist activities. Consistent with other reports 
(Williams et al., 2000), our finding showed that EGCG antagonized induced CYPl 
gene expression. Nevertheless, the 4 theaflavins did not produce significant effects 
on XRE-mediated gene transcription, whereas TF3 and DMBA co-administration led 
to a slight induction. Subsequent semi-quantitative RT-PCR experiments confirmed 
that theaflavins did not inhibit AHR mediated CYPl expression. Cotreatment of 
DMBA and theaflavins even led to a slight increase in CYPlAl mRNA expression. 
It was suggested that the chemoprotective activities of theaflavins on 
DMBA-induced carcinogenesis were not related to their modulating ability on CYPl 
activities. On the other hand, EGCG inhibited DMBA-induced CYPlAl and 
CYPIBI mRNA expressions. 
Feng et al. (2002) report that theaflavins suppress OME-induced CYPlAl 
activities. The difference between this and our studies is that we use DMBA to 
induce CYPl activities. DMBA is a mammary carcinogen that stimulates the 
transcription of CYPl enzymes via AhR, a signal transduction pathway distinct from 
the protein tyrosine kinase-mediated pathway. As suggested by Feng et al. (2002)， 
theaflavins may stimulate tyrosine receptor kinase activity to block 
omeprazole-induced CYP1A1. 
In conclusion, this report showed that EGCG from green tea is a potent 
chemopreventive agent that antagonises AHR-mediated CYPl induction and inhibits 
CYPl enzyme activities. Theaflavins from black tea also possess inhibitory effects 




CHAPTER 5 ISOFLAVONES PREVENT 
DMBA-INDUCED CARCINOGENESIS BY INHIBITING 
CYPlAl AND CYPIBI ACTIVITIES 
Introduction 
Of all the phytochemicals that are currently under intense investigation, perhaps 
none has received as much attention as isoflavones found in soybean, chick peas and 
other legumes. Numerous studies have shown that isoflavones have multi-biological 
and pharmacological properties. They are estrogenic and antiestrogenic compounds 
(Ren et al., 2001). Others like antiproliferative effect (Kuntz et al., 1999), induction 
of cell-cycle arrest, apoptosis (Matsukawa et al, 1993; Shapiro et al., 1999) as well 
as cellular signaling (Agawal, 2000) are also described. Based on these properties, 
isoflavones have been associated with reduced incidences of breast and prostate 
cancers (Busby et al., 2002), cardiovascular diseases or osteoporosis (Goldwyn et al., 
2000; Pollard et al., 2000), and exhibit some other favorable effects. 
Genistein, daidzein are primary aglycone isoflavones in soybeans while 
biochanin A is a methylated derivative of genistein isolated from red clover, 
Trifolium pratense (Table 5.1). Tlie anticarcinogenic effects of these isoflavones are 
well-documented (Rosenberg et al.，2002; Birt et al., 2001). They have the potential 
in protecting against cancers on several fronts. Being weak estrogens, they are 
postulated to reduce the risk of estrogen-related cancers by receptor competition 
(Naik et al.，1994). They possess antiproliferative and apoptotic properties (Zhou et 
al., 1998). Moreover, they are effective antioxidants that scavenge free-radicals and 
prevent oxidative DNA-damage. Another proposed mechanism for protection against 
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cancer by these isoflavones may include modification of carcinogen metabolizing 
enzymes that results in the reduction of activated carcinogens. This can be 
accomplished by coupling the inhibition of phase I activating enzymes and induction 
of phase 11 detoxification enzymes. Genistein and biochanin A are inducers of the 
phase n enzyme NAD(P)H: quinone reductase (QR), while daidzein has no 
significant effect on it (Wang et al., 1998; Sun et al., 1998). To date, few researches 
have been carried out to investigate the effects of biochanin A and daidzein on phase 
I activating enzymes. Kishida et al. (2000) have shown that genistein and daidzein do 
not induce CYP content in liver microsomes of mice. By contrast, Helsby et al. (1998) 
have demonstrated that genistein inhibits mouse CYPlAl and CYP2E1 -dependent 
substrate metabolism in vitro. Furthermore, genistein has been reported to be a 
tyrosine kinase inhibitor that suppresses both dioxin and OME-induced CYPlAl but 
not CYPIBI expression (Kikuchi et al., 1999). Daidzein inhibits CYPlAl enzymes 
activities in mice (Shertzer et al.，1999)，while the role of biochanin A on CYPl 
enzyme inhibition remains unclear. 
It has been demonstrated that genistein and daidzein have potent 
chemopreventive activities against DMBA-induced carcinogenesis in rats (Wei et al., 
1995; Giri et al., 1995), whereas biochanin A reduces B[a]P-induced toxicity in mice 
and mammalian cell culture (Cassady et al, 1888; Chae et al., 1991). This effect is 
attributed to，in part, the ability of isoflavones to inhibit carcinogen-DNA adduct 
formation. However, the possible roles of them on CYPl metabolizing enzymes have 
not been fully elucidated. Therefore, in the present study, we would like to 
investigate the effects of these isoflavones on the expression and activities of CYPl 
enzymes in mammary cell cultures. 
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5 6 7 4' 
Biochanin A ‘ OH H OH OMe 
Genistein OH H OH OH 
Daidzein H H OH OH 
Table 5.1 Chemical structures of isoflavones. 
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Results 
Isoflavones inhibited DMBA-induced EROD activity in MCF-7 cells 
CYPlAl and CYPIBI activities were measured as EROD activity in intact cells. 
DMBA caused approximately 2-fold increase in EROD activity compared with 
controls (Data not shown). Co-treatment with genistein and biochanin A suppressed 
this induction in a concentration dependent manner, with IC50 of approximately 12 
jiM and 0.57 jiM respectively (Figure 5.2A and B). Nevertheless, the suppressive 
effect of daidzein was less effective. Only <30% of DMBA-induced EROD activity 
was inhibited by 50 |aM of daidzein (Figure 5.2C). The above data indicated that 
biochanin A was the most effective in suppressing DMBA-induced EROD activity 
among the three. Treatments with isoflavones alone only have slight inhibition on 
EROD activities in MCF-7 cells (Figure 5.3). 
Inhibition of MCF-7 microsomal EROD activities by isoflavones 
The effects of isoflavones on EROD activities were determined on microsomal 
fractions from DMBA-treated MCF-7 cells (Figure 5.4). Isoflavones treatment 
resulted in a concentration-dependent decrease in EROD activities. Among them, 
biochanin A was the most potent inhibkor with IC50 value of ~8 |iM, followed by 
genistein. Daidzein was the least potent inhibitor. 
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Figure 5.4 Effects of isoflavones on microsomal EROD activities. 
Microsomes were isolated from. MCF-7 cells treated with l(a,M DMBA for 24 h. 
Then EROD activities in 10 jig microsomes were measured in the presence of 
indicated concentration of isoflavones. EROD activities in all isoflavones-treated 
samples were statistically different from the controls (P < 0.05). The values are 
means 土SE，n=3. 
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Kinetic analysis of the inhibition of human recombinant CYPl enzymes by 
isoflavones 
To further characterize the inhibition of CYPlAl and CYPIBI catalytic 
activities by isoflavones, enzymes kinetic experiments using human recombinant 
CYPlAl and CYPIBI enzymes were carried out. Figure 5.5 provided a general view 
on the inhibitory effects of various isoflavones on recombinant CYPlAl and 
CYPIBI enzymes. The inhibitory ability of isoflavones on both CYPlAl and 
CYPIBI activities were in the order biochanin A> genistein> daidzein. 
Lineweaver-Burk and inset plot showed that the 3 isoflavones exhibited mixed type 
inhibition on CYPlAl enzymes whereas they competitively inhibited CYPIBI 
enzymes. Based on the corresponding Ki values (Figure 5.9), we may conclude that 
biochanin A was the most effective inhibitor on both CYPlAl and CYPIBI 
activities among the 3 isoflavones. 
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Figure 5.5 Inhibition of isoflavones on human recombinant CYPlAl and 
CYPIBI activities. 
EROD assay (400nM ER) was performed with 2.5 pmole of CYPlAl (A) and 2 
pmole of CYPIBI (B) enzymes and varying concentration of theaflavins and EGCG. 
The values are means 士SE, n=3. All values are significantly different (P >0.05) form 
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Figure 5.6A Lineweaver-Burk plot of biochanin A on CYPlAl enzymes 
inhibition. 
EROD assay was performed with human recombinant CYPlAl at the indicated 
concentration of biochanin A and 100-1600 nM ER as described under Material and 
Methods. Lineweaver-Burk plot was generated by linear regression of the reciprocal 
data. Inset, replot of the slopes from the Lineaweaver-Burk plot, with derivation of 
Ki. Values shown are mean 土SE，n=3. 
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Figure 5.6B Lineweaver-Burk plot of biochanin A on CYPIBI enzymes 
inhibition. 
EROD assay was performed with human recombinant CYPIBI at the indicated 
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Figure 5.7A Lineweaver-Burk plot of genistein on CYPlAl enzymes 
inhibition. 
EROD assay was performed with human recombinant CYPlAl at the indicated 
concentration of genistein and 100-1600 nM ER as described under Material and 
Methods. Lineweaver-Burk plot were generated by linear regression of the reciprocal 
data. Inset, replot of the slopes from the Lineaweaver-Burk plot, with derivation of 
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Figure 5.7B Lineweaver-Burk plot of. genistein on CYPIBI enzymes 
inhibition. 
EROD assay was performed with human recombinant CYPIBI at the indicated 
concentration of genistein and 100-1600 nM ER as described in figure 5.7A. 
79 
CHAPTER 5 
• 0 i^M / y 
El 10 - O 100 _ Z Z I • 250 _ / / Z 
吞 , V 400 一 / / Y 
G A • 500 NM / / Z 
- n , . T T T T - n ~ , ^ ^ , ~ , ^ ^ , I — I / / 
-30a200-100 0 100200300400 500600 J t r 
[Daidzein] M^ ^ ^ ^ i • ^^^ 1 . 1 1 . . -4 -2 0 2 4 6 8 10 12 l/[Ethoxyresorufin] (JIM) 
Figure 5.8A Lineweaver-Burk plot of daidzein on CYPlAl enzymes 
inhibition. 
EROD assay was performed with human recombinant CYPlAl at the indicated 
concentration of daidzein and 100-1600 nM ER as described under Material and 
Methods. Lineweaver-Burk plot were generated by linear regression of the rcciprocaJ 
data. Inset, replot of the slopes from the Lineaweavcr-Burk plou with derivation of 




40 ] , 
A • 0 _ / 
% � 1 . 0 HM / Y / y 
— ^ ^ • 2.5 i^M / / ^ y 
-20l«161412108-6-4-20 2 4 6 81012 • 10 " 
[Daidzein] _ 
I r ^^ I 1 1 1 1 1 1 
-4 -2 0 2 4 6 8 10 12 
l/[Ethoxyresorufin] (|aM) . ‘ 
Figure 5.8B Lineweaver-Burk plot of daidzein on CYPIBI enzymes 
inhibition. 
EROD assay was performed with human recombinant CYPIBI at the indicated 





Biochanin A 4 0.59 
Genistein 15.35 0.677 
Daidzein 319 18.82 
Figure 5.9 Competitive Ki value for isoflavones on CYPl inhibition. 




XRE-driven Luciferase activities 
MCF-7 cells were transfected with XRE fused to a luciferase reporter gene and 
luciferase activity was subsequently measured to index AhR-mediated transcription. 
DMBA induced luciferase activity by 6.5-fold above control level. The addition of 5 
|iM biochanin A produced a 65% reduction in DMBA-induced luciferase activities 
(Figure 5.1 OA), while 25 |iM of genistein resulted in a 99% reduction (Figure 
5.10B). Nevertheless, daidzein had no effect at this level (Figure 5.IOC). Treatment 
with daidzein alone led to a 3.2-fold increase in XRE-mediated luciferase activity 
compared with control, which indicated that daidzein was an agonist for 
XRE-dependent transactivation (Figure 5.11C). Both biochanin A (Figure 5.11 A) 
and genistein (Figure 5.1 IB) induced XRE-driven luciferase activity at low 
concentration. 
Both biochanin A and genistein suppressed DMBA-induced CYPl mRNA 
expression 
DMBA induced CYPlAl, CYPIBI mRNA expression by 6.6- and 3.1-fold 
above basal levels, respectively. The increases were abated in a concentration 
dependent manner with genistein co-treatment (Figure 5.13). Treatment with 5 |iM 
of biochanin A showed the greatest reduction on both DMBA-induced CYPlAl and 
CYPIBI mRNA levels (Figure 5.12). Daidzein had no effect on CYPlAl mRNA 
level and caused a slight but significant {P< 0.05) increase on DMBA-induced 
CYPIBI mRNA levels at 10 and 25 i^M (Figure 5.14). 
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Figure 5.12 Effect of Biochanin A on DMBA-induced CYPlAl and 
CYPIBI mRNA expression. 
MCF-7 cells were seeded in 6-well culture plates and treated with 1 |LLM DMBA and 
various concentrations of baicalein for 24 h. Total RNA was then isoJated and 
semi-quantitative RT-PCR was used to determine the relative mRNA expressions. 
Figure 5.7A is the gel image of the ethidium bromide-stained PGR fragments. Figure 
5.7B and C are the optical density readings of the CYPlAl and CYPIBI fragments. 
Values are means 土SE，n=3 . Means without same letters differ (P<0.05). 
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Figure 5.13 Effect of genistein on DMBA-induced CYPl mRNA expression. 
C Y P l A l and C Y P l B1 n i R N A expression alter trcalnicni with D M B A and genistein 
was invest igated as descr ibed in f igure 5.7. Figure 5.8A is the gel image of the 
c ihidiuni hmnik le - s ta incd PGR fragmenis . Figure 5.8B and C arc the optical densi ty 
readings. Values arc means ±SE, n=3. Means without same Id le rs di f fer (厂<0.05). 
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Figure 5.14 Effect of daidzein on DMBA-induced CYPl mRNA expression. 
CYPlAl and CYPIBI mRNA expression after treatment with DMBA and daidzein 
was investigated as described in figure 5.7. Figure 5.9A is the gel image of the 
ethidium bromide-stained PGR fragments. Figure 5.9B and C are the optical density 
readings. Values are means 土SE，n=3. Means with same letters differ (P<0.05). 
Cytotoxicity of DMBA and isoflavones co-treatment 
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To test the effects of isoflavones on DMBA toxicity, the cell viability of MCF-7 
was measured by MTT assay after 72 h of incubation with indicated concentration of 
DMBA in the presence or absence of 2.5 juM isoflavones. All 3 isoflavones inhibited 
DMBA-induced cytotoxicity (Figure 5.15). Biochanin A was the most effective 
agent that rescued MCF-7 cells from DMBA-induced cell death, followed by 
daidzein and finally genistein. All isoflavones，by themselves had no effect on cell 
viability after 24h of treatment until their concentration reached 100 |lM (Figure 
5.16). 
Isoflavones reduced the binding of activated DMBA to DNA 
The above results showed that isoflavones modulated the expression and 
activities of CYPl enzymes. To analyze the effects of isoflavones on DMBA 
metabolism, tritiated DMBA was added to MCF-7 cells in the presence or absence of 
isoflavones and the amount of [^H]DMBA-DNA adduct was measured by 
scintillation counting. Genistein treatment resulted in concentration dependent 
reduction of [^H]DMBA-DNA adducts formation (Figure 5.17B) and 5 |LLM of 
biochanin A could reduce DNA-adduct formation by 50% (Figure 5.17A). However, 
daidzein inhibited less than 25% [^H]DMBA-DNA adduct formation at a 
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Figure 5.15 The cytotoxic effects of DMBA and isoflavones on MCF-7 cells. 
MCF-7 cells were cultured in 96-well plates. DMBA ranged from 0 to 1 jjM was 
added to the cultures, and 0 \iM (Control) or 2.5 jiM isoflavones; biochanin A (A), 
genistein (B) and daidzein (C) were co-administered with DMBA. After 72 h of 
treatment, the cell viability percentage was assayed. Values are means 土SE，n=6 . 
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Numerous reports have been demonstrated the board chemopreventive effects of 
isoflavones against cancer. They exhibit apoptotic, antiproliferative and antioxidative 
activities in different animal models. Most of the current researches are focusing on 
their estrogenic and antiestrogenic activities, which may attribute to their ability to 
prevent hormone-related cancers. Nevertheless, no conclusive results have yet been 
obtained because of substantial variations. Some suggest that isoflavones may only 
protect against hormone-related cancer when administered prepubertally. Others 
report the possible role of isoflavones on inhibiting chemical induced carcinogenesis. 
Previous studies demonstrate that isoflavones inhibit DMBA-DNA adduct formation 
in different models. The present report evaluated the role of isoflavones on PAHs 
metabolism by using MCF-7 cells. 
MCF-7 cells may be regarded as an applicable model to study the effects of 
chemopreventive agents on carcinogens metabolism (Giri et al.，1995, Upadhyaya et 
al., 1998; Shertzer et al.，2001; Fritz et al., 1998 Lamartiniere et al.，1995). We 
showed that the 3 isoflavones reduced DMBA genotoxicity in various extents with 
biochanin A > genistein > daidzein. The chemopreventive properties of isoflavones 
might attribute to their activities in diminishing. DMBA-metabolism mediated by 
CYPl enzymes. CYPl enzymes have been demonstrated to activate DMBA that may 
attack biological macro molecules and results in mutation (Gonzalez et al., 1994). 
Inhibition of CYPl activities by phytochemicals has been suggested to inhibit 
xenobiotics-induced genotoxicity. The 3 isoflavones were shown to be either agonist 
or antagonist for microsomal and human recombinant CYPl activities (Figure 
5.4-5.5). Furthermore, genistein and biochanin A inhibited DMBA-induced CYPl at 
the transcription level (Figure 5.10). By contrast, Shertzer et al. (1999) have 
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demonstrated that genistein and daidzein inhibit TCDD-induced CYPlAl activities 
without affecting CYPlAl gene transcription in a liver cancer cell line HepG2. In 
accord with our finding, genistein inhibits dioxin-dependent expression of CYPlAl 
human keratinocytes, possibly by acting at the binding domain of the AHR (Gradin 
et al., 1994). On the other hand, Backlund et al. (1997) have shown that genistein 
does not inhibit B[a]P induced CYPlAl in rat hepatoma cells. Isoflavones also 
induce the activities of phase n conjugating enzymes (Giri et al., 1995; Appelt et al., 
1999). It is possible that isoflavones speed up the clearance of carcinogens by the 
induction of phase H detoxification. Isoflavones alone are weak agonists to AHR at 
low concentrations. Certain phytochemicals are natural ligands for AhR which 
compete with other AhR ligands such as DMBA or TCDD. This can give rise to the 
chemopreventive activities of these phytochemicals (Ciolino et al.，（1998，1999); 
‘ » 
McDonald et al.，（2001)� 
The hydroxyl groups at 5 and 7 positions of the isoflavone molecules and the 
phenolic group at C-2 are critical for the inhibitory action of phytochemicals on 
xenobiotics-induced carcinogenesis (Chae et al” 1991; 1992; Lee et al.，1994). In the 
present studies, biochanin A with a methoxy group at the 4’ position was more active 
than genistein. Daidzein, which has hydroxyl groups at position 4’ and 7 but lacks a 
hydroxyl group at the 5th position, was not active. Thus, the hydroxyl group at the 
5-position was essential for inhibition of DMBA metabolism. The presumed upper 
limit for the serum genistein concentration in those on a high soy diet was estimated 
to be 13.2 |iniole/L (5 micrograms/mL) (Barnes, 1995). Although the effective 
dosage of genistein in inhibiting DMBA-induced CYPl activities was shown to be 
-10 |xM, it was suggested that metabolism of genistein in vivo may potentiate their 
effects. So, the current cell culture experimental result may applicable in vivo 
(Boersma et al.，2001). Surely, further investigation is required to elucidate the 
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activities and metabolism of isoflavones in vivo. 
Studies from Peterson et al. (1996) investigate the metabolism of biochanin A 
and genistein in MCF-7 cells. Both compounds were found to be extensively 
metabolized in MCF-7 cells. Biochanin A is converted into genistein 7-sulfate, 
genistein and another hydroxylated and methylated form of genistein 7-sulfate. On 
the other hand, 2 genistein metabolites are identified to be genistein and genistein 
7-sulfate. Thus, the metabolism of biochanin A into genistein may account for its 
» • 
similar potency in preventing DMBA-induced carcinogenesis when compared to 
genistein in the present study. In addition, the presence of hydroxylated and 
methylated genistein 7-sulfate metabolite after biochanin A treatment may attribute 
to the relatively higher potency of biochanin A in inhibiting CYPl activities. 
Actually, this compound is reported to be inhibitory to cancer cell proliferation 
(Peterson et al., 1998). Daidzein can be metabolized by gut microflora into equol 
(Setchell et al., 1984) and equol is reported to be a potent CYPl A inhibitor in vitro 
(Helsby et al., 1998). In the present study, daidzein may weakly antagonizes 
DMBA-induced CYPl activities. Our results demonstrated that phytochemicals 
metabolism did play a crucial role on their bioavailability and bio activity. 
In conclusion, this report demonstrated genistein and biochanin A suppressed 
CYPl expression and activities, and inhibited DMBA-DNA adduct formation in 
MCF-7 cells. Daidzein was less effective than the other two isoflavones. 
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CHAPTER 6 IN VITRO EFFECTS OF BAICALEIN AND 
THEAFLAVINS ON RAT HEPATIC P 4 5 0 ACTIVITIES 
Introduction 
In the previous chapters, baicalein and theaflavins demonstrated antimutagenic 
properties and diverse effect on CYPl enzymes in mammalian cell culture. Baicalein 
inhibited DMBA-induced CYPl activities (EC 50 = 0.97 |iM) and the formation of 
DMBA-DNA adduct. Although theaflavins did also reduce DMBA toxicity, it had no 
effects on DMBA-induced CYPl activities. In this chapter, their effects on hepatic 
P450 activities were determined by measuring ethoxyresorufin 0-deethoxylase and 
methoxyresorufin 0-demethylase activities in rat microsomes. Cytochrome P450 
enzymes are involved in the metabolic activation and detoxification of environmental 
carcinogens. The differences between this and the previous studies were that no PAH 
was used to induce the CYPl activities and fat microsomes instead of human 
microsomes were used. EROD and MROD activities from untreated rat liver were 
catalyzed mainly by CYP2C6 and CYP1A2 respectively (Burke et al., 1994; Levine 
et al., 1998). Constitutively expressed CYP2C6 are develop mentally regulated P450 
in rat liver. It plays a role in the biotransformation of various carcinogens including 
DMBA, thalidomide and sulfamethoxazole (Morrison et al., 1991; Ando et al., 2002; 
Cribb et al., 1995) while the resulting reactive metabolites was proposed to increase 
oxidative stress. Being the predominant CYP 450 enzyme in rat liver, CYP1A2 
catalyse stereoselective epoxidation of a series of PAHs and nitrosamines to 
carcinogens (Shou et al., 1996) and plays a role in metabolizing important 
xenobiotics such as caffeine and propranolol (Brosen, 1995). Evaluating the 
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influence of baicalein and theaflavins on microsomal CYP2C6 and CYP1A2 





Inhibition of EROD and MROD activities in rat liver microsomes by baicalein 
To evaluate the effects of baicalein on rat hepatic CYP2C6 and CYP1A2 
activities, microsomal EROD and MROD activities were assayed with various 
concentrations of baicalein. Both activities in microsomes isolated from rat liver 
were potently inhibited by baicalein in a dose-dependent manner. Baicalein was more 
effective in inhibiting MROD activity when compared with EROD activity. The IC50 
values are 4 jilM and 1 jiM for EROD and MROD inhibition respectively. Figure 6.2 
and 6.3 showed that baicalein was a competitive inhibitor for EROD activity by 
competing with ER for the active site without undergoing the catalytic steps. Replot 
of the slopes obtained by linear regression of the data indicated that the Ki for 
competitive inhibition of baicalein on EROD activity was 0.4 |iM. Ki is the 
dissociation constant for inhibitor binding which represent the affinity of inhibitor to 
enzymes. The lower is the Ki; the higher is the affinity. Baicalein also acted as a 
competitive inhibitor for CYP1A2 activity and the Ki value was approximately 0.2 
|iM (Figure 6.3). 
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Figure 6.1 Direct effects of baicalein on microsomal EROD and MROD 
activity. 
The EROD and MROD activities in 5 jig of microsomes isolated from rat livers were 
measured in the presence of 400 nM ER/MR and the indicated concentration of 
baicalein. The values are means 土SE，n=3 . 
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Figure 6.2 Lineweaver-Burk plot of baicalein on the EROD inhibition. 
EROD activity in 5 jig of microsomes was measured in the presence of various 
concentrations of baicalein and 100-1600 nM ER and the double reciprocal plot was 
generated. The values are means ±SE，n=3. Inset, replot of the slopes obtained by 
linear regression of the data from the Lineweaver-Burk plot, with derivation of Ki, 
which was equal to 0.4 \iM. 
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Figure 6.3 Lineweaver-Burk plot of baicalein on the MROD inhibition. 
lines shown here were determined by linear regression of the reciprocal data as 
described in figure 6.2. Ki value was equal to 0.2 |iM. 
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Effects of theaflavins on EROD and MROD activities in rat liver microsomes 
To elucidate the structural feature governing theaflavins interaction with 
CYP2C6 and CYP1A2 enzymes, the 4 theaflavins with various concentrations were 
assayed for their EROD and MROD activities in the presence of 400 nM of ER/MR. 
TFl was the most potent inhibitor for CYP2C6, followed by TF2B, TF2A and TF3 
(Figure 6.4A). All TFs showed a less potent inhibition for CYP1A2 compared with 
TFl (Figure 6.4B). In figure 6.4 C，the IC50 values for EROD and MROD activities 
were plotted inversely in order to facilitate the comparison of their relative potencies. 
TFl was the most potent CYP2C6 and 1A2 inhibitors and was approximately 2 fold 
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Figure 6.4 Direct effects of theaflavins on microsomal EROD and MROD 
activities. 
The EROD (A) and MROD (B) activities in 5 jLig of microsomes isolated from rat 
livers were measured in the presence of 400 nM ER/MR and the indicated 
concentration of theaflavins. The values are means 士SE，n=3. Figure 6.4C was the 
reciprocal plot of IC50 for EROD and MROD activities of theaflavins. 
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Kinetic studies for EROD and MROD activities of theaflavins 
In addition, kinetic analyses of the EROD and MROD activities of rat liver 
microsomes were performed. With TFl, competitive inhibition was observed for 
CYPlAl with a Ki value of 0.7 |LIM (Figure 6.5). Mixed-type inhibition of CYP1A2 
by TFl was observed (Figure 6.6). It indicated that this compounds could con^ete 
for substrate binding at the active site, and also might bind to a region that did not 
participate directly in substrate binding. For EROD activity, TF2A exhibited a 
competitive mode of inhibition (Figure 6.7). A 2-fold selectivity for CYP2C6 over 
mixed type inhibition of CYP1A2 (Figure 6.8) was observed by comparing their Ki 
value. The inhibition by TF2B on both EROD (Figure 6.9) and MROD (Figure 6.10) 
activities were mixed type with Ki value of 0.8 and 2 [iM respectively. TF3 
competitively inhibited EROD activities and the Ki value was as low as 0.8 |iM 
(Figure 6.11). However, a large Ki value was observed in mixed type inhibition of 
CYPlA2-mediated MROD activity (Figure 6.12). Figure 6.13 illustrated the 




1299^  ^ _ 120 - • 0 _ j X 
/ S O l ^ M / 10000 / / / 100 - • 2mM / - / f t • • 8 _ / 身 誦 . / I I 8 0 - / 
• / g I . z 
2000 / g 6 0 - Z _ _ . I y A ^ ^ 
0 2 4 6 8 1 � 4 0 - / ^ ^ 
岡 MM . y ^ ^ 
~r—^ r^ 0-TI 1 1 1 1 1 1 
-0.004 -0.002 0.000 0.002 0.004 0.006 0.008 0.010 0.012 
l / [ E t h o x y r e s o n i f m ] ( n M ) 
Figure 6.5 Lineweaver-Burk plot of TFl on the EROD inhibition. 
EROD acthdty in 5 jig of microsomes was measured in the presence of various 
concentrations of TFl and 100-1600 nM ER and the double reciprocal plot was 
generated. The values are means ±SE，n=3. Inset, replot of the slopes obtained by 
linear regression of the data from the Lineweaver-Burk plot, with derivation of Ki, 
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Figure 6.6 Lineweaver-Burk plot of TFl on the MROD inhibition. 
Lines shown here were determined by linear regression of the reciprocal data as 
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Figure 6.7 Lineweaver-Burk plot of TF2A on the EROD inhibition. 
EROD activity in 5 |ig of microsomes was measured in the presence of various 
concentrations of TF2A and 100-1600 nM ER and the double reciprocal plot was 
generated. The values are means 土S E，n = 3 . Inset, replot of the slopes obtained by 
linear regression of the data from the Lineweaver-Burk plot, with derivation of Ki, 
which was equal to 0.7 jiM. 
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Figure 6.8 Lineweaver-Burk plot of TF2A on the MROD inhibition. 
lines shown here were determined by linear regression of the reciprocal data as 
described in figure 6.7. Ki value was equal to 1.3 [iM. 
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Figure 6.9 Lineweaver-Burk plot of TF2B on the EROD inhibition. 
EROD activity in 5 [ig of microsomes was measured in the presence of various 
concentrations of TF2B and 100-1600 nM ER and the double reciprocal plot was 
generated. The values are means 土S E，n = 3 . Inset, replot of the slopes obtained by 
linear regression of the data from the Lineweaver-Burk plot, with derivation of Ki, 
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Figure 6.10 Lineweaver-Burk plot of TF2B on the MROD inhibition. 
Lines shown here were determined by linear regression of the reciprocal data as 
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Figure 6.11 Lineweaver-Burk plot of TF3 on the EROD inhibition. 
EROD activity in 5 |LLg of microsomes was measured in the presence of various 
concentrations of TF3 and 100-1600 nM ER and the double reciprocal plot was 
generated. The values are means 土SE，n=3. Inset, replot of the slopes obtained by 
linear regression of the data form the Lineweaver-Burk plot, with derivation of Ki, 
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Figure 6.12 Lineweaver-Burk plot of TF3 on the MROD inhibition. 
lines shown here were determined by linear regression of the reciprocal data as 
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Figure 6.13 Competitive Ki value for baicalein and theaflayins on EROD 
and MROD inhibition. 
This figure concluded the competitive Ki value for baicalein and theaflavins on 




The 0-dealkylation of selected alkoxyresorufin is used in laboratory to 
determine the activity of isoform of cytochrome P450. In untreated rat liver 
microsomes, antibody inhibition studies showed that EROD is catalyzed mainly by 
CYP2C6 whereas MROD activity is catalysed mainly by constitutive CYP1A2 
(Burke et al., 1994). Isoforms of cytochrome P450 metabolize both endogenous and 
exogenous compounds such as steroids, therapeutic drugs and chemical carcinogens. 
Modulation of cytochrome P450 by phytochemicals may render the 
activation/detoxification of theses substrates. 
Baicalein and theaflavins are naturally occurring compounds that are suggested 
to be anticarcinogenie (Ikemoto et al., 2000; Isemura et al., 2000). Baicalein by itself 
induces both EROD and MROD activities in rats. Co-administration of baicalein and 
DMBA shows a reduction of CYPl activities, which inhibits the mutagenicity of 
DMBA and possibly other PAHs in human breast cancer cells. In this study, baicalein 
exhibited the most potent competitive inhibition of EROD and MROD activities on 
CYP2C6 and CYP1A2 in a concentration-dependent manner. 
Theaflavins are polyphenols in black tea that exert protective effect in DNA 
oxidative damage (Feng et al., 2002). They are reported to have antimutagenicity in 
rat liver S9 fraction and are suspected to inhibit cytochrome P450 enzymes 
(Apostolides et al., 1997). Our studies from chapter 4 showed that theaflavins 
inhibited CYPl enzymes activities in vitro but not in vivo. They reduced 
DNA-damage in breast cancer cells by suppressing DMBA-DNA adduct formation. 
The present studies showed that the 4 theaflavins inhibited both EROD and MROD 
activities in rat microsomes. Among the 4 theaflavins, TF3 was the most potent 




all of them inhibited CYP2C6 to a greater extent than CYP1A2. TF3 displayed 
almost 5-fol(l selectivity for inhibiting CYP2C6 over CYP1A2. As mentioned above, 
CYP2C6 and CYP1A2 are responsible for procarcinogens metabolism whereas 
CYP1A2 also play an important role on drug metabolism. Accordingly, inhibition of 
CYP2C6 and CYP1A2 by baicalein and theaflavins may render their activities. 
In summary, this study suggested that baicalein and theaflavins had various 
inhibitory effects upon CYP2C6 and CYP1A2 in vitro and therefore might affect the 
metabolism of their substrates. 
4 
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CHAPTER 7 CONCLUSION 
In this study, we investigated effects of baicalein, theaflavins, EGCG and 
isoflavones on CYPl enzyme activities and DMBA-DNA adduct formation in a 
human breast cancer cell line MCF-7. The results indicated that all the above 
phytochemicals were capable to reduce DMBA genotoxicity in various extents. 
Baicalein, EGCG, biochanin A and genistein suppressed DMBA-induced CYPl 
activities and expressions in MCF-7 cells, whereas theaflavins had no effects at this 
level. 
CYPl enzyme inhibition offers a possible basis for the inhibitory effects of 
certain phytochemicals against PAHs genotoxicity. However, Izzotti et al. (1999) 
suggest that the ideal detoxification agent should modulate both phase I and phase II 
pathways, resulting in the increased elimination of procarcinogens. Because of the 
complexity of the xenobiotic metabolizing system, thoughtful assessment for the 
activities of potential chemopreventive agents will definitely help characterizing their 
roles. On the other hand, it has been proposed that protection against one group of 
compounds may potentiate the toxic/ carcinogenic effects of another class of 
toxicants or vice versa (Sy et al.，2001). Thus, chemopreventive studies that research 
on agents manipulating xenobiotic metabolizing enzymes should be approached with 
caution. 
In reality, it is difficult to evaluate the net effect of chemoprotective agents 
because exposure to many different environmental toxins and carcinogens occurs 
concurrently. Vakharia et al. (2001) show that metals could diminish PAH induced 
CYPlAl activity in human hepatoma cells. In addition, it has been demonstrated that 
the metabolism of phytochemicals does play an important role on their 
chemopreventive bioavailability and bioactivity. Thus, one should never overlook the 
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importance of phytochemical metabolism. Actually, extensively studies have been 
carried out on the bioavailability of chemopreventive agents in different models 
(Fang et al.，2002; Peterson et al.，1998). 
Our experiments herein evaluated the effects of baicalein, theaflavins, EGCG 
and isoflavones on PAH-induced CYPl activities and DMBA genotoxicity in the 
human breast tumor cell line MCF-7. We showed that baicalein, EGCG, genistein 
and biochanin A reduced DMBA carcinogenicity by modulating CYPl enzymes 
activities and DMBA-DNA adduct formation. Whether these confounds interact 
similarly with other xenobiotic metabolizing enzymes remain to be determined. 
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Code Sequence 
CYPlAl FOR 5，- TAGACACTGATCTGGCTGCAG -3’ 
CYPlAl REV 5，- GGGAAGGCTCCATCAGCATC -3’ 
P-actin FOR 5，- GTGGGGCGCCCCAGGCACCA -3’ 
p-actin REV 5，- CTCCTTAATGTCACGCACGATTTC -3 ’ 
CYPIBI FOR 5，- AACGTCATGAGTGCCGTGTGT -3’ 
CYPIBI REV 5，- GGCCGGTACGTTCTCCAAATC -3， 
XRE FOR 5'-CCGAGCATTGCACGAAACC -3' 
XRE REV 5'-CATACTGAAGCAGGCGACAC -3’ 
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Name Components 
lOx dNTP solution 2 mM dATP, dCTP, dGTP, dTTP 
lOx PCR buffer 200 mM Tris-Cl pH8.4 at 23 °C, 500 mM KCl, 25 mM 
MgCl2 
Cell lysis buffer (mammalian) 50 mM Tris-HCl (pH 7.5), 250 mM NaCl，5 mM 
EDTA, 50 mM NaF, 0.2% v/v Nonidet P-40 
LB medium 1 % w/v tryptone, 0.5 % w/v yeast extracts, 1 % w/v 
NaCl 
LB plate LB medium, 1.5 % w/v agar 
LB 猶P medium LB medium, 100 |Lig/ ml ampicilin 
lb咖P plate LB medium, 1.5% w/v agar, 200 |Lig/ml ampicilin 
"Pl 50 mM Tris-Cl (pH 8.0)，10 mM EDTA, 10% w/v 
RNaseA 
200 mM NaOH, 1% w/v SDS 
~P3 3 M KOAc, pH5.5 
PBS 0.8% w/v NaCl, 0.02% w/v KCl, 0.08% w/v 
Na2HP04*2H20, 0.02% w/v KH2PO4 
Protease inhibitors 1 rtiM PMSF, 0.1% w/v leupeptin, 0.2% w/v 叩rotinin， 
1% w/v soybean trypsin inhibitor, 1.5% w/v 
benzamidine, 1 % w/v chymostatin, 1 % w/v pepstatin 
QBT 750 mM NaCl, 50 mM MOPS (pH 7.0)，15% v/v 
isopropanol, 0.15% v/v Triton X-100 
1 M NaCl, 50 mM MPOS (pH 7.0)，15% v/v 
isopropanol 
1.25 M NaCl, 50 mM Tris-Cl (pH 8.5)，15% v/v 
isopropanol 
Sodium phosphate buffer 0.08 M monobasic sodium phosphate, 0.12 M dibasic 
sodium phosphate 
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TAE buffer 40 mM Tris-OAc (pH 8.0), 40 mM HO Ac, 2 mM 
EDTA 
TBE buffer 90 mM Tris-OAc (pH 8.0), 90 mM boric acid, 2 mM 
EDTA 
TEST “ 10 mM Tris-Cl (pH 8.0), 150 mM NaCl, 0.05% 
Tween-20 
f E 10 mM Tris-Cl (pH 8.0)，1 mM EDTA 
*The components of all homemade reagents are listed. For the commercially 
purchased reagents, please refer to the manufacturers' manual. 
120 
BIBLIOGRAPHY 
Agarwal,R. Cell signaling and regulators of cell cycle as molecular targets for prostate 
cancer prevention by dietary agents. Biochem. Pharmacol 60，1051-1059 (2000). 
Alexander,D.L., Eltom^S.E. & Jefcoate，C.R. Ah receptor regulation of CYPIBI 
expression in primary mouse embryo-derived cells. Cancer Res. 57，4498-4506 
(1997). 
Apostolides,Z., Balentine，D.A.，Harbowy,M.E., Hara,Y. & Weisburger，J.H. Inhibition 
of PhIP mutagenicity by catechins, and by theaflavins and gallate esters. Mutat. Res. 
389，167-172(1997). 
Apostoli(ies,Z., Balentine,D.A., Harbowy，M.E.，Hara,Y. & Weisburger，J.H. Inhibition 
of PhIP mutagenicity by catechins, and by theaflavins and gallate esters. Mutat Res. 
389, 167-172(1997), 
Appelt,L.C. & Reicks，M.M. Soy induces phase II enzymes but does not inhibit 
dimethylbenz[ajanthracene-induced carcinogenesis in female rats. J. Nutr. 129, 
1820-1826 (1999). 
Backlund,M., Johansson,!., Mkrtchian,S. & Ingelmaii-Sundberg,M. Signal 
transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma 
H4皿 cells. J. Biol Chem. 272，31755-31763 (1997). 
Bames，S. Effect of genistein on in vitro and in vivo models of cancer. J. Nutr. 125， 
777S-783S (1995). 
Bimbaum,L.S. Endocrine effects of prenatal exposure to PCBs, dioxins, and other 




Birt，D.F.，Hendrich，S. & Wang，W. Dietary agents in cancer prevention: flavonoids and 
isoflavonoids. Pharmacol Ther. 90，157-177 (2001). 
Boersma,B.J., Bames，S.，Kirk,M., Wang，C.C.，Smith，M.，Kim,H., Xu，J,，Patel，R.， 
Darley-Usmar,V.M. Soy isoflavonoids and cancer ~ metabolism at the target site. 
Mutat. Res. 480-481，121-127 (2001). 
Brosen，K. Drug interactions and the cytochrome P450 system. The role of cytochrome 
P450 1A2. Clin. PharmacoUnet 29 Suppl 1，20-25 (1995). 
Burke,M.D., Thompson,S., Weaver,RJ., Wolf,C.R. & Mayer，R.T. Cytochrome P450 
specificities of alkoxyresorafin 0-dealkylation in human and rat liver. Biochem. 
Pharmacol 48，923-936 (1994). 
Busby,M.G., Jeffcoat，A.R.，Bloedon,L.T., Koch，M.A，. Black,T., Dix，K.J., Heizer，W.D.， 
Thomas,B.F., HillJ.M., Crowell，J.A•，Zeisel，S.H. Clinical characteristics and 
pharmacokinetics of purified soy isoflavones: single-dose administration to healthy 
men. Am. J. Clin. Nutr. 75，126-136 (2002). 
ButersJ.T., Sakai,S., Richter,T., Pineau,T.，Alexander,D.L., Savas,U., DoehmerJ., 
WardJ.M., Jefcoate,C.R., Gonzalez,FJ. Cytochrome P450 CYPIBI determines 
susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl. 
Acad. ScL U. S. A 96, 1977-1982 (1999). 
CassadyJ.M., Zemiie,T.M., Chae，Y.H.，Ferin，M.A.，Portuondo,N.E., Baird,W.M. Use 
of a mammalian cell culture benzo(a)pyrene metabolism assay for the detection of 
potential anticarcinogens from natural products: inhibition of metabolism by 
biochanin A, an isoflavone from Trifolium pratense L. Cancer Res. 48, 6257-6261 
(1988). 
Chae，Y.H.，Coffing，S丄,，Cook，V.M.，Ho，D.K.，CassadyJ.M., Baird,W.M. Effects of 
biochanin A on metabolism, DNA binding and mutagenicity of benzo[a]pyrene in 
mammalian cell cultures. Carcinogenesis 12，2001-2006 (1991). 
122 
BIBLIOGRAPHY 
Chae,Y,H., Ho，D.K.，CassadyJ.M., Cook,V.M., Marcus,C.B., Baird,W.M. Effects of 
synthetic and naturally occurring flavonoids on metabolic activation of 
benzo[a]pyrene in hamster embryo cell cultures. Chem. Biol, Interact 82, 181-193 
(1992). 
Chang,C.Y. & Puga，A. Constitutive activation of the aromatic hydrocarbon receptor. 
Mol Cell Biol 18，525-535 (1998). 
Chen，S.，Ruan,Q., Bedner，E.，Deptala,A., Wang，X.，Hsieh，T.C.，Traganos，R， 
Darzynkiewicz,Z. Effects of the flavonoid baicalin and its metabolite baicalein on 
androgen receptor expression, cell cycle progression and apoptosis of prostate cancer 
cell lines. CellProlif. 34, 293-304 (2001). 
Chou,RP., Chu，Y.C.， HsuJ.D., Chiang,HC. & Wang，C.J. Specific induction of 
glutathione S-transferase GSTM2 subunit expression by epigallocatechin gallate in 
rat liver. Biochem. Pharmacol 60，643-650 (2000). 
Ciolino,H.P. & Yeh，G.C. Inhibition of aryl hydrocarbon-induced cytochrome P-450 
lAl enzyme activity and CYPlAl expression by resveratrol. Mol Pharmacol 56, 
760-767 (1999). 
aolino，H.P. & Yeh，G.C. The flavonoid galangin is an inhibitor of CYPlAl activity 
and an agonist/antagonist of the aryl hydrocarbon receptor. Br. J. Cancer 79， 
1340-1346 (1999). 
Ciolino,H.P., Daschner,PJ. & Ydi，G.G. Dietary flavonols quercetin and kaempferol 
are ligands of the aryl hydrocarbon receptor that affect CYPlAl transcription 
differentially. Biochem J. 340 ( Pt 3)，715-722 (1999). 
Ciolino，H.P.，Daschner,PJ., Wang,T.T. & Yeh，G.C. Effect of curcumin on the aryl 
hydrocarbon receptor and cytochrome P450 1 Al in MCF-7 human breast carcinoma 
cells. Biochem. Pharmacol 56，197-206 (1998). 
123 
BIBLIOGRAPHY 
Conney，A.H.，Chang,R.L., Jerina,D.M. & Wei，S.J. Studies on the metabolism of 
benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its 
ultimate carcinogenic metabolite. Drug Metab Rev. 26，125-163 (1994). 
CorcheroJ., Pimprale,S., Kimura,S. & Gonzalez，F.J. Organization of the CYPl A 
cluster on human chromosome 15: implications for gene regulation. 
Pharmacogenetics 11，1-6 (2001). 
Couture，L.A” Abbott,B.D. & Bimbaum，L.S. A critical review of the developmental 
toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances 
toward understanding the mechanism. Teratology 42，619-627 (1990). 
Cribb,A.E., Spielberg,S.P. & Griffin,G.P. N4-hydroxylation of sulfamethoxazole by 
cytochrome P450 of the cytochrome P4502C subfamily and reduction of 
sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab 
Dispos. 23，406-414 (1995). 
Dashwood,R.H., Xu,M., HemaezJ.E, Hasaniya,N., Youn,K., Razzuk,A. Cancer 
chemopreventive mechanisms of tea against heterocyclic amine mutagens from 
cooked meat. Proc. Soc. Exp. Biol. Med. 220，239-243 (1999). 
DialynaJ.A., Arvanitis,D.A. & Span(iicios，D.A. Genetic polymorphisms and 
transcriptional pattern analysis of CYPlAl, AhR, GSTMl, GSTPl and GSTTl 
genes in breast cancer. Int. J. Mol Med. 8，79-87 (2001). 
Dipple, A. et a I In Diet and Cancer; Markers, Prevention and Treatment; Jacobs M.M， 
Ed.; Plenum Press: New York, 1994; p 101. 
Dipple, A., Pigott,M.A., Bigger,C.A., Blake,D.M. 7,12-dimethylbenz[a] 
anthracene—DNA binding in mouse skin: response of different mouse strains and 
effects of various modifiers of carcinogenesis. Carcinogenesis. 5，1087-90 (1984). 
124 
BIBLIOGRAPHY 
Dohr,0., Vogel,C. & Abel,J. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. 
Arch. Biochem. Biophys. 321，405-412 (1995). 
DbreostiJ.E., Wargovich,MJ. & Yang，C.S. Inhibition of carcinogenesis by tea: the 
evidence from experimental studies. Crit Rev. Food Sci. Nutr. 37, 761-770 (1997). 
Environmental Protection Agency (1990) Aerometric Information Retrieval System 
(AIRS), Data for 1985-1990. Environmental Protection Agency, Research Triangle 
Park, NC. 
Fang，N., Yu，S. & Ba(lger，T.M. Characterization of isoflavones and their conjugates in 
female rat urine using LC/MS/MS. J. Agric. Food Chem. 50, 2700-2707 (2002). 
Feng,Q., Torii，Y.，Uchida,K., Nakamura,Y., Hara,Y., Osawa,T. Black tea polyphenols, 
theaflavins, prevent cellular DNA damage by inhibiting oxidative stress and 
suppressing cytochrome P450 l A l in cell cultures. J, Agric. Food Chem. 50, 
213-220 (2002). 
Fritz,W.A., Coward，L.，Wang,J. & Lamartimere，C.A. Dietary genistein: perinatal 
mammary cancer prevention, bioavailability and toxicity testing in the rat 
Carcinogenesis 19, 2151-2158 (1998). 
Giri, A. K. & Lu，L.J. Genetic damage and the inhibition of 
7,12-dimethylbenz[a]anthracene-induced genetic damage by the phytoestrogens, 
genistein and daidzein, in female ICR mice. Cancer Lett. 95, 125-133 (1995). 
Goldwyn，S.，Lazinsky,A. & Wei，H. Promotion of health by soy isoflavones: efficacy, 
benefit and safety concerns. Drug Metahol Drug Interact. 17, 261-289 (2000). 
Gonzalez,FJ. & Gelboin，H.V. Role of human cytochromes P450 in the metabolic 
activation of chemical carcinogens and toxins. Drug Metab Rev. 26，165-183 (1994). 
125 
BIBLIOGRAPHY 
Gradin,K., Whitelaw，M.L.，Toftgard，R.，Poellinger,L. & Bei:ghard，A. A tyrosine 
kinase-dependent pathway regulates ligand-dependent activation of the dioxin 
receptor in human keratinocytes. J. Biol Chem. 269，23800-23807 (1994). 
Guengerich,F.P. & Shima(la，T. Activation of procarcinogens by human cytochrome 
P450 enzymes. Mutat. Res. 400，201-213 (1998). 
Guengerich，F.P. Reactions and significance of cytochrome P-450 enzymes. J. Biol 
Chem, 266，10019-10022 (1991). 
Hammons,G.J. et al Effects of chemoprotective agents on the metabolic activation of 
the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver 
microsomes. Nutr. Cancer 33, 46-52 (1999). 
HaimaJ.H.，Dawling，S.，Roodi,N., Guengerich，F.P. & Parl，F.F. Cytochrome P450 IBl 
(CYPIBI) pharmacogenetics: association of polymorphisms with functional 
differences in estrogen hydroxylation activity. Cancer Res. 60，3440-3444 (2000). 
Helsby,N.A., ChipmanJ.K., Gescher,A. & K£rr，D. Inhibition of mouse and human 
CYP lA- and 2E1-dependent substrate metabolism by the isoflavonoids genistein 
and equol Food Chem, Toxicol 36，375-382 (1998). 
Hemminki，K.，Koskinen，M.，Rajaniemi,H. & Zhao，C. Dna adducts, mutations, and 
cancer 2000. Regul Toxicol Pharmacol 32，264-275 (2000). 
Huang，H.C.，Wang，H.R. & Hsieh，L.M. Antiproliferative effect of baicalein, a 
flavonoid from a Chinese herb, on vascular smooth muscle cell. Eur. J. Pharmacol 
251, 91-93 (1994). 
Huang，H.C.，Wang,H.R. & Hsieh，L.M. Antiproliferative effect of baicalein, a 
flavonoid from a Chinese herb，on vascular smooth muscle cell. Eur. J. Pharmacol 
251, 91-93 (1994). 
126 
BIBLIOGRAPHY 
Ikemoto,S., Sugimura,K., Yoshida,N., Yasumoto，R.， Wada,S., Yamamoto,K., 
Kishimoto,T. Antitumor effects of Scutellariae radix and its components baicalein, 
baicalin, and wogonin on bladder cancer cell lines. Urology 55，951-955 (2000). 
International Agency for Research on Cancer (1983) Polynuclear aromatic compounds, 
part I，chemical, environmental and experimental data. In lARC Monographs on the 
Evaluation of the Carcinogenic Risk of Chemicals to Human, Vol.32, lARC, Lyon, 
pl-453. 
Isemura,M., Saeki，K.，Kimura,T., Hayakawa，S.，Minami,T., Sazuka,M. Tea catechins 
and related polyphenols as anti-cancer agents. Bio factors 13，81-85 (2000). 
Izzotti,A. Camoimno，A.，Cartiglia,C., Gmbbs，C.J.，Lubet,R.A., KeUoff，G.J.，De 
Flora,S. Patterns of DNA adduct formation in liver and mammary epithelial cells of 
rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of 
chemopreventive agents. Cancer Res. 59，4285-4290 (1999). 
Jeffy，B.D. Schultz,E.U., Selmin,0., GudasJ.M., Bowden，G.T.，Romagnolo,D. 
Inhibition of BRCA-1 expression by benzo[a]pyrene and its diol epoxide. Mol 
Carcinog. 26，100-118 (1999). 
Karki,N.T., Pokela，R.，Nuutinen,L. & Pelkonen，0. Aryl hydrocarbon hydroxylase in 
lymphocytes and lung tissue from lung cancer patients and controls. Int. J. Cancer 39， 
565-570 (1987). 
Katiyar,S.K. & Mukhtar，H. Tea antioxidants in cancer chemoprevention. J. Cell 
Biochem. Suppl 27，59-67 (1997). 
Katiyar，S.K.， Agarwal，R.， Wang，Z.Y.， Bhatia,A.K. & Mukhtar，H. 
(-)-Epigallocatechin-3 -gallate in Camellia sinensis leaves from Himalayan region of 
Sikkim: inhibitory effects against biochemical events and tumor initiation in Senear 
mouse skin. Nutr. Cancer 18, 73-83 (1992). 
127 
BIBLIOGRAPHY 
Katiyar，S.K.， Agarwal,R., Zaim,M.T. & Miikhtar，H. Protection against 
N-nitrosodiethylamine and benzo[a]pyrene-induced forestomach and lung 
tumorigenesis in A/J mice by green tea. Carcinogenesis 14，849-855 (1993). 
Kavanagh，K.T.，Hafer,L.J., Kim,D.W., Mann，K.K.， Sherr,D.H., Rogers，A. E.， 
Sonenshein,G.E. Green tea extracts decrease carcinogen-induced mammary tumor 
burden in rats and rate of breast cancer cell proliferation in culture. J. Cell Biochem. 
82，387-398 (2001). 
Kawajiri，K.，Nakachi,K., Imai,K., WatanabeJ. & Hayashi，S. The CYPlAl gene and 
cancer susceptibility. Crit Rev. Oncol Hematol 14，77-87 (1993). 
Kikuchi,H. & Hossain，A. Signal transduction-mediated CYPlAl induction by 
omeprazole in human HepG2 cells. Exp. Toxicol Pathol 51，342-346 (1999). 
Kim，J.H.，Stansbury,K.H., Walker,NJ., Trush，M.A.，Strickland,P.T., Sutter,T.R. 
Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-ciiol by human cytochrome 
P450 IBl . Carcinogenesis 19，1847-1853 (1998). 
KimJ.Y., Lee,S., Kim,D.H., Kim，B.R.，Park,R., Lee，B.M. Effects of flavonoids 
isolated from Scutellariae radix on cytochrome P-450 activities in human liver 
microsomes. J. Toxicol Environ. Health A 65, 373-381 (2002). 
Kishida,T., Nashiki,K., Izumi,T. & Ebihara，K. Soy isoflavonoid aglycons genistein and 
daidzein Do not increase the cytochrome P-450 content of the liver microsomes of 
mice. J. Agric. Food Chem. 48，3872-3875 (2000). 
Kleiner，H.E.，Vulimiri,S.V., Reed,MJ., Uberecken,A. & DiGiovanni，J. Role of 
cytochrome P450 la l and Ibl in the metabolic activation of 
7,12-dimethylbenz[a]anthracene and the effects of naturally occurring 
furanocoumarins on skin tumor initiation. Chem. Res, Toxicol 15, 226-235 (2002). 
128 
BIBLIOGRAPHY 
Kriek，E.， Rojas，M.， Alexandre v,K. & Bartsch，H. Polycyclic aromatic 
hydrocarbon-DNA adducts in humans: relevance as bio markers for exposure and 
cancer risk. Mutat. Res. 400，215-231 (1998). 
Kronenberg,S., Esser,C. & Carlberg，C. An aryl hydrocarbon receptor conformation 
acts as the functional core of nuclear dioxin signaling. Nucleic Acids Res. 28， 
2286-2291 (2000). 
Kuntz，S.，Wenzel,U. & Daniel，H. Comparative analysis of the effects of flavonoids on 
proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur, J. 
Nutr. 38, 133-142(1999). 
Lamartimere,C.A., Moo re, J. B., Brown,N.M., Thompson,R., Hardin,M.J., Barnes,S. 
Genistein suppresses mammary cancer in rats. Carcinogenesis 16，2833-2840 (1995). 
Landi,M.T., Sinha,R., Lang，N.P. & Kadlubar，F.F. Chapter 16. Human cytochrome 
P4501A2.1 ARC Set Publ 173-195 (1999). 
Larsen，M.C.，Angus，W.G.，Brake,RB., Eltom,S.E., Sukow，K.A.，Jefcoate，C.R. 
Characterization of CYPIBI and CYPlAl expression in human mammary epithelial 
cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon 
metabolism. Cancer Res. 58, 2366-2374 (1998). 
Lee,B.M., JangJJ. & Kim，H.S. Benzo[a]pyrene diol-epoxide-I-DNA and oxidative 
DNA adducts associated with gastric adenocarcinoma. Cancer Lett. 125, 61-68 
(1998). 
Lee,H., Wang,H.W., Su，H.Y. & Hao，N.J. The structure-activity relationships of 
flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and 




Leung,L.K., Su，Y.，Chen，R.，Zhang,Z., Huang,Y., Chen，Z.Y. Theaflavins in Mack tea 
and catechins in green tea are equally effective antioxidants. J. Nutr. 131，2248-2251 
(2001). 
Levine，M.，Law，E.Y.，Bandiera,S.M., Chang,T.K. & Bellward，G.D. In vivo cimetidine 
inhibits hepatic CYP2C6 and CYP2C11 but not CYPlAl in adult male rats. J. 
Pharmacol Exp. Ther. 284, 493-499 (1998). 
Ii，D.，Firozi，P.R，Wang,L.E., Bosken，C.H.，Spitz,M.R., Hong，W.K.，Wei,Q. Sensitivity 
to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a 
case-control analysis. Cancer Res. 61，1445-1450 (2001). 
Ii,D., Wang,M., Dhingra,K. & Hittelman，W.N. Aromatic DNA adducts in adjacent 
tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res. 56， 
287-293 (1996). 
Iiang，Y.C.，Lin-shiau,S.Y., Chen,C.F. & LinJ.K. Suppression of extracellular signals 
and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in 
human A431 epidermoid carcinoma cells. J. Cell Biochem. 67, 55-65 (1997), 
Lin，C.C. & Shieh，D.E. The anti-inflammatory activity of Scutellaria rivularis extracts 
and its active con^onents, baicalin, baicalein and wogonin. Am. J. Chin Med. 24， 
31-36 (1996). 
Lusska,A., Wu,L. & Whitlock，J.P.，Jr. Superinduction of CYPlAl transcription by 
cycloheximide. Role of the DNA binding site for the liganded Ah receptor. J. Biol 
Chem. 267，15146-15151 (1992). 
MacDonald,CJ., Ciolino,H.P. & Yeh，G.C. Dibenzoylmethane modulates aryl 
hydrocarbon receptor function and expression of cytochromes P50 lAl , 1A2, and 
IBL Cancer Res. 61，3919-3924 (2001). 
130 
BIBLIOGRAPHY 
Matsukawa，Y.，Marui,N., Sakai,T., Satomi,Y., Yoshida，M.，Matsumoto，K.，Nishino，H•， 
Aoike,A. Genistein arrests cell cycle progression at G2-M. Cancer Res. 53， 
1328-1331 (1993). 
Mosmann,T. Rapid colorimetric assay for cellular growth and survival: application to 
proliferation and cytotoxicity assays. J. Immunol Methods 65，55-63 (1983). 
Motoo，Y. & Sawabu，N. Antitumor effects of saikosaponins, baicalin and baicalein on 
human hepatoma cell lines. Cancer Lett, 86，91-95 (1994). 
Mukhtar,H. & Ahmad,N. Green tea in chemoprevention of cancer. Toxicol Sci. 52， 
111-117 (1999). 
Murray,G.L, Taylor，M.C.，McFadyen，M.C.，McKay,J.A., Greenlee,W.R, Burke,M.D., 
Melvin,W.T. Tumor-specific expression of cytochrome P450 CYPIBI. Cancer Res. 
57,3026-3031 (1997). 
Naik，H.R.，LehrJ.E. & Pienta，K.J. An in vitro and in vivo study of antitumor effects of 
genistein on hormone refractory prostate cancer. Anticancer Res. 14，2617-2619 
(1994). 
Nakahata,N., Kutsuwa,M., Kyo,R.，Kubo,M., Hayashi，K.，Ohizumi，Y. Analysis of 
inhibitory effects of Scutellariae radix and baicalein on prostaglandin E2 production 
in rat C6 glioma cells. Am. J. Chin Med. 26，311-323 (1998). 
Nebert,D.W., Puga,A. & Vasiliou，V. Role of the Ah receptor and the dioxin-inducible 
[Ah] gene battery in toxicity, cancer, and signal transduction. Ann. N. Y. Acad. Sci. 
685, 624-640(1993). 
Oetari，S.，Sudibyo，M.，CommandeurJ.N., Samhoedi，R. & Vermeulen，N.P. Effects of 
curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. 
Biochem Pharmacol 51，39-45 (1996). 
131 
BIBLIOGRAPHY 
Ohishi,T., Kishimoto,Y., Mium，N.，Shiota,G., Kohri，T.，Hara，Y.，Hasegawa，J.， 
Isemura,M. Synergistic effects of (-)-epigallocatechin gallate with sulindac against 
colon carcinogenesis of rats treated with azoxymethane. Cancer Lett. 177, 49-56 
(2002). 
Peterson，T.G.，Coward,L., Kirk，M.，Falany,C.N., Bames，S. The role of metabolism in 
mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin 
A. Carcinogenesis. 17，1861-1869 (1996). 
Peterson,T.G. Ji，G.P.，Kirk，M.，Coward,L., Falany,C.N., Bames,S. Metabolism of the 
isoflavones genistein and biochanin A in human breast cancer cell lines. Am. X Clin 
Nutr. 68，1505S-1511S (1998). 
PoUard，M. & Wolter，W. Prevention of spontaneous prostate-related cancer in 
Lobund-Wistar rats by a soy protein isolate/isoflavone diet. Prostate 45，101-105 
(2000). 
Ren,M.Q., Kuhn，G.， WegnerJ. & Chen，J. Isoflavones, substances with 
multi-biological and clinical properties. Eur. J. Nutr. 40，135-146 (2001). 
Roberts，E.A.，Fumya,K.N., Tang，B.K. & Kalow，W. Caffeine biotransformation in 
human hepatocyte lines derived from normal liver tissue. Biochem. Biophys. Res. 
Commun. 201，559-566 (1994). 
Rosenberg Zand,R.S., Jenkins,DJ., Brown,TJ. & Diamandis，E.P. Flavonoids can 
block PSA production by breast and prostate cancer cell lines. Clin. Chim. Acta 317， 
17-26 (2002). 
Rundle,A., Tang,D., Hibshoosh,H., Estabrook,A., Schnabel,F., Cao，W.，Grumet，S.， 
Perera,F.P. The relationship between genetic damage from polycyclic aromatic 




Sazuka,M., Imazawa,H., Shoji，Y.，Mita，T.，Hara，Y.，Isemura，M. Inhibition of 
collagenases from mouse lung carcinoma cells by green tea catechins and black tea 
theaflavins. Biosci. Biotechnol, Biochem. 61，1504-1506 (1997). 
Schut,H.A. & Yao,R. Tea as a potential chemopreventive agent in PhIP carcinogenesis: 
effects of green tea and black tea on PhlP-DNA adduct formation in female F-344 
rats. Nutr, Cancer 36, 52-58 (2000). 
Schwarz，D.， Kisselev，P.， Cascorbi,!., Schunck,W.H. & RootsJ. Differential 
metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human 
CYPlAl variants. Carcinogenesis 22，453-459 (2001). 
Setchell,K.D., Bomello,S.P., Hulme，P•，Kirk,D.N. & Axelson，M. Nonsteroidal 
estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. 
Nutr. 40，569-578 (1984). 
Shapiro,G.I., Koestner,D.A., Matxanga,C.B. & Rollins，B.J. Flavopiridol induces cell 
cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines. 
Clin. Cancer Res. 5，2925-2938 (1999). 
Shertzer,H.G. et al Inhibition of CYPlAl enzyme activity in mouse hepatoma cell 
culture by soybean isoflavones. Chem. Biol Interact 123, 31-49 (1999). 
Shimada,T., Puga,A., Chang,C, Smith,P., Nebert,D.W.，SetcheU，K.D.，Dalton，T.P. 
Activation of chemically diverse procarcinogens by human cytochrome P-450 IBl. 
Cancer Res. 56，2979-2984 (1996). 
Shimizu,Y., Nakatsum,Y., Ichinose,M., Takahashi,Y., Kume，H.， MimuraJ.， 
Fujii-Kuriyama,Y., Ishikawa,T. Benzo[a]pyrene carcinogenicity is lost in mice 




Shou，M.，Gonzalez，F.J. & Gelboin，H.V. Stereoselective epoxidation and hydration at 
the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes 
P450 lA l , 1A2, and epoxide hydrolase. Biochemistry 35, 15807-15813 (1996). 
Smith TJ; Yang CS In Food Phytochemicals for Cancer Prevention I Fruits and 
Vegetables; Huang MT; Osawa T; Ho CT; Rosen RT, Ed.; American Chemical 
Society: Washington, DC, 1994; p 17. 
Smith,L.E., Denissenko,M.F., Bennett,W.P., Li，H.，Amin,S., Tang，M.，Pfeifer,G.R 
Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J. 
Natl. Cancer Inst. 92，803-811 (2000). 
Smith,W.A., Freeman,!.W. & Gupta^R.C. Effect of chemopreventive agents on DNA 
adduction induced by the potent mammary carcinogen dibenzo[a,l]pyrene in the 
human breast cells MCF-7. Mutat Res. 480-481，97-108 (2001). 
Spink,B.C., Fasco，MJ.， GierthyJ.F. & Spink，D.C. 
12-0-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially 
alters CYPIBI and CYPlAl expression in MCF-7 breast cancer cells. J, Cell 
Biochem. 70, 289-296 (1998). 
Steele, V.E. KeUoff，G.J.， Balentine，D.， Boone，C.W.， Mehta,R., Bagheri,D.， 
Sigman，C.C.，Zhu，S” Sharma,S. Comparative chemopreventive mechanisms of green 
tea, black tea and selected polyphenol extracts measured by in vitro bio assays. 
Carcinogenesis 21，63-67 (2000). 
Stoner,G.D. & Mukhtar,H. Polyphenols as cancer chemopreventive agents. J, Cell 
Biochem. Suppl 22, 169-180 (1995). 
Suganuma,M., Okabe,S., Sueoka,N., Sueoka,E., Matsuyama,S., Imai,K., Nak:achi,K., 
Fujiki,H. Green tea and cancer chemoprevention. Mutat Res. 428, 339-344 (1999). 
134 
BIBLIOGRAPHY 
Suganuma,M., Okabe，S.，Kai，Y.，Sueoka,N., Sueoka,E., Fujiki，H. Synergistic effects of 
(-)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on 
cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res. 59, 
44-47 (1999). 
Sun，X.Y.， Plouzek,C.A., HenryJ.P., Wang,T.T. & Phang，J.M. Increased 
UDP-glucuronosyltransferase activity and decreased prostate specific antigen 
production by biochanin A in prostate cancer cells. Cancer Res. 58, 2379-2384 
(1998). 
Suter，T.R.，Tang，Y.M•，Hayes，C.L” Wo，Y.Y.，Jabs，E.W.，Li,X.，Yin，H.，Cody，C.W.， 
Greenlee,W.F. Complete cDNA sequence of a human dioxin-inducible mRNA 
identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. 
Biol. Chem. 269，13092-13099 (1994). 
Sy，S.K.， Tang，B.K.， Pastrakuljic，A.， Roberts,E.A. & Kalow，W. Detailed 
characterization of experimentally derived human hepatic CYPlAl activity and 
expression using differential inhibition of ethoxyresorufin 0-deethylation by 
fluvoxamine. Eur. J. Clin. Pharmacol 57, 377-386 (2001). 
Tang，Y.M.，Wo，Y.Y.，Stewart,!., Hawkins,A.L., Griffin,C.A., Sutter,T.R., Greenlee,W.F. 
Isolation and characterization of the human cytochrome P450 CYPIBI gene. J. Biol 
Chem. 271，28324-28330 (1996). 
Taylor,M.C., McKay,J.A., Murray,G.L, Greenlee,W.F., Marcus,C.B., Burke，M.D.， 
Melvin,W.T. Cytochrome P450 IBl expression in human malignant tumours. 
Biochem Soc. Trans. 24，328S (1996). 
Tian’Y.，Ke，S., Demson，M.S.，Rabson，A.B. & Gallo，M.A. Ah receptor and NF-kappaB 




Trombino，A.R，Near,R.I.，Matulka,R.A., Yang，S.，Hafer，L.J” Tosem，P.A•，Kim，D.W.， 
Rogers,A.E., Sonenshein,G.E., Sherr,D.H. Expression of the aryl hydrocarbon 
receptor/transcription factor (AhR) and AhR-regulated CYPl gene transcripts in a rat 
model of mammary tumorigenesis. Breast Cancer Res. Treat, 63，117-131 (2000). 
Ueng，Y.R，Shyu,C.C., Lin，Y.L.，Park,S.S., LiaoJ.R, Chen，C.F. Effects of baicalein and 
wogonin on dmg-metabolizing enzymes in C57BL/6J mice. Life Set 67, 2189-2200 
(2000). 
Ueng，Y.F.，Shyu，C.C.，Liu，T.Y.，Oda,Y., Lin，Y.L.，UaoJ.R, Chen,C.F. Protective 
effects of baicalein and wogonin against beiizo[a]pyrene- and aflatoxin B(l)-induced 
genotoxicities. Biochem. Pharmacol 62，1653-1660 (2001). 
Upadhyaya,P. & El Bayoumy，K. Effect of dietary soy protein isolate, genistein, and 
1,4-phenylenebis(methylene) selenocyanate on DNA binding of 
7,12-dimetliylbenz[a]anthracene in mammary glands of CD rats. Oncol Rep. 5, 
1541-1545 (1998). 
Vadlamuri,S.V., Glover,D.D., Turner,T. & Sarkar，M.A. Regiospecific expression of 
cytochrome P4501A1 and IBl in human uterine tissue. Cancer Lett. 122，143-150 
(1998). 
Vakharia,D.D., Liu，N.，Pause，R., Fasco，M.，Bessette,E., Zhang,Q.Y, Kaminsky,L.S. 
Polycyclic aromatic hydro carbon/metal mixtures: effect on PAH induction of 
CYPlAl in human HEPG2 cells. Drug Metab Dispos. 29，999-1006 (2001). 
Wang,T.T. & Phang，J.M. Effects of estrogen on apoptotic pathways in human breast 
cancer cell line MCF-7. Cancer Res. 55，2487-2489 (1995). 
Wang,W., Liu,L.Q., Higuchi,C.M. & Chen，H. Induction of NADPH:quinone reductase 




Wang，Z.Y.，Khan,W.A., Bickers，D.R. & Mukhtar，H. Protection against polycyclic 
aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols. 
Carcinogenesis 10，411-415 (1989). 
Wei，H.，Bo wen,R., Zhang,X. & Lebwohl，M. Isoflavone genistein inhibits the initiation 
and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis 19， 
1509-1514(1998). 
WeisburgerJ.H., Rivenson,A., ReinhardtJ., Aliaga,C., BraleyJ., Pittman，B.，Zang,E. 
Effect of black tea on azoxymethane-induced colon cancer. Carcinogenesis 19， 
229-232 (1998). 
WilleyJ.C., Coy,E.L., Frampton,M.W., Torres,A., Apostolakos,MJ., Hoehn,G., 
Schuermaim,W.H., Thilly，W.G.， 01son，D.E.， HammersleyJ.R., Crespi，C.L.， 
Utell,M.J. Quantitative RT-PCR measurement of cytochromes p450 lAl , IBl , and 
2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung 
cells of smokers and nonsmokers. Am. J. Respir. Cell Mol Biol. 17，114-124 (1997). 
Williams,J.A. & Phillips，D.H. Mammary expression of xenobiotic metabolizing 
enzymes and their potential role in breast cancer. Cancer Res. 60，4667-4677 (2000). 
Williams,J.A. et al Determination of the enzymes responsible for activation of the 
heterocyclic amine 2-amino-3-methyliniidazo[4,5-f]quinoline in the human breast. 
Pharmacogenetics 8, 519-528 (1998). 
Williams,S.N., Shih，H.，Guenette,D.K., Brackney,W., Denison，M.S.，Pickwell，G.V.， 
Quattrochi,L.C. Comparative studies on the effects of green tea extracts and 
individual tea catechins on human CYPl A gene expression. Chem. Biol. Interact. 
128,211-229 (2000). 
Xu，M. & Dashwood,R.H. Chemoprevention studies of heterocyclic amine-induced 
colon carcinogenesis. Cancer Lett. 143, 179-183 (1999). 
137 
BIBLIOGRAPHY 
Xu，Y.，Ho，C.T.，Amin，S.G” Han，C. & Chung，F.L. Inhibition of tobacco-specific 
nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major 
polyphenol as antioxidants. Cancer Res. 52，3875-3879 (1992). 
Yang，C.S.，Maliakal,P. & Meng，X. Inhibition of carcinogenesis by tea. Annu. Rev. 
Pharmacol Toxicol 42，25-54 (2002). 
Yang，C.S.，Prabhu，S. & Landau,J. Prevention of carcinogenesis by tea polyphenols. 
Drug Metab Rev. 33, 237-253 (2001). 
ZhouJ.R., Mukheijee,R, Gugger，E.T.，Tanaka,T., Blackbum,G.L., Clinton,S.K. 
Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the 
cell cycle, apoptosis, and angiogenesis. Cancer Res. 58，5231-5238 
138 

CUHK L i b r a r i e s 
I • • 圓 
